{"messages":[{"status":"ok","interval":"2020-03-21:2020-03-24","cursor":"45","count":61,"count_new_papers":106,"total":106}], "collection":[{"doi":"10.1101\/2020.03.19.20039131","title":"Assessing the potential impacts of COVID-19 in Brasil: Mobility, Morbidity and Impact to the Health System","authors":"Coelho, F. C.; Lana, R. M.; Cruz, O. G.; Codeco, C. T.; Villela, D.; Bastos, L. S.; Piontti, A. P. y.; Davis, J. T.; Vespignani, A.; Gomes, M. F. C.","author_corresponding":"Marcelo F.C. Gomes","author_corresponding_institution":"Fiocruz, Scientific Computing Program, Rio de Janeiro, Brazil","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039131.source.xml","abstract":"BackgroundBrazil detected community transmission of COVID-19 on March 13, 2020. In this study we identify which areas in the country are most vulnerable for COVID-19, both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission. The micro-regions with higher social vulnerability are also identified.\n\nMethodsProbabilistic models were used to calculate the probability of COVID-19 spread from Sao Paulo and Rio de Janeiro, according to previous data available on human mobility in Brazil. We also perform a multivariate cluster analysis of socio-economic indices to identify areas with similar social vulnerability.\n\nResultsThe results consist of a series of maps of effective distance, outbreak probability, hospital capacity and social vulnerability. They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly vulnerable.\n\nInterpretationThe maps produced are useful for authorities in their efforts to prioritize actions such as resource allocation to mitigate the effects of the pandemic and may help other countries to use a similar approach to predict the virus route in their countries as well.\n\nFundingNo funding","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20039164","title":"Role of meteorological temperature and relative humidity in the January-February 2020 propagation of 2019-nCoV in Wuhan, China","authors":"Alvarez-Ramirez, J.; MERAZ, M.","author_corresponding":"Jose Alvarez-Ramirez Sr.","author_corresponding_institution":"Universidad Autonoma Metropolitana-Iztapalapa","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039164.source.xml","abstract":"Identified in December 2019, the 2019-nCoV emerged in Wuhan, China, and its spread increased rapidly, with cases arising across Mainland China and several other countries. By January 2020, the potential risks imposed by 2019-nCoV in human health and economical activity were promptly highlighted. Considerable efforts have been devoted for understanding the transmission mechanisms aimed to pursue public policies oriented to mitigate the number of infected and deaths. An important question requiring some attention is the role of meteorological variables (e.g., temperature and humidity) in the 2019-nCoV transmission. Correlations between meteorological temperature and relative humidity with the number of daily confirmed cases were explored in this work for the epicenter city of Wuhan, China for the period from 29 January to March 6, 2020. Long-term trend of temperature and relative humidity was obtained with a 14-days adjacent-averaging filter, and lagged correlations of the number of daily confirmed cases were explored. The analysis showed negative correlations between temperatures with the number of daily confirmed cases. Maximum correlations were found for 6-day lagged temperatures, which is likely reflecting the incubation period of the virus. It was postulated that the indoor crowding effect is responsible of the high incidence of 2019-nCoV cases, where low absolute humidity and close human contact facilitate the transport of aerosol droplets.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038968","title":"Modelling the epidemiological trend and behavior of COVID-19 in Italy","authors":"Rovetta, A.; Bhagavathula, A. S.","author_corresponding":"Alessandro Rovetta","author_corresponding_institution":"Mensana srls","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038968.source.xml","abstract":"As of May 14, 2020, Italy has been one of the red hotspots for the COVID-19 pandemic. With over 220,000 confirmed cases and almost 33,000 confirmed deaths reported from February, it is necessary to fully understand the spread of COVID-19 in this country. By S.E.I.R. simulation, we estimated the most representative basic reproduction number R0 for the three most affected regions from February 22 to March 14, 2020. In doing so, we have been able to evaluate the consistency of the first containment measures until the end of April, as well as identify possible SARS-CoV-2 local behavior mutations and specificities. Next to that, through new estimates of the infection mortality rate, we recalculated a more plausible number of real infected. Finally, given the absolutely anomalous trend of the Lombardy region, we looked for correlations between COVID-19 total cases and air pollutants such as PM 10 and PM 2.5.","published":"10.7759\/cureus.9884","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20037192","title":"Trend analysis of the COVID-19 pandemic in China and the rest of the world","authors":"Weber, A.; Iannelli, F.; Goncalves, S.","author_corresponding":"Sebastian Goncalves","author_corresponding_institution":"Instituto de Fisica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20037192.source.xml","abstract":"The recent epidemic of Coronavirus (COVID-19) that started in China has already been \"exported\" to more than 140 countries in all the continents, evolving in most of them by local spreading. In this contribution we analyze the trends of the cases reported in all the Chinese provinces, as well as in some countries that, until March 15th, 2020, have more than 500 cases reported. Notably and differently from other epidemics, the provinces did not show an exponential phase. The data available at the Johns Hopkins University site [1] seem to fit well an algebraic sub-exponential growing behavior as was pointed out recently [2]. All the provinces show a clear and consistent pattern of slowing down with growing exponent going nearly zero, so it can be said that the epidemic was contained in China. On the other side, the more recent spread in countries like, Italy, Iran, and Spain show a clear exponential growth, as well as other European countries. Even more recently, US --which was one of the first countries to have an individual infected outside China (Jan 21st, 2020)-- seems to follow the same path. We calculate the exponential growth of the most affected countries, showing the evolution along time after the first local case. We identify clearly different patterns in the analyzed data and we give interpretations and possible explanations for them. The analysis and conclusions of our study can help countries that, after importing some cases, are not yet in the local spreading phase, or have just started.\n\nHIGHLIGHTSO_LIAll the provinces of China show very similar epidemic behaviour.\nC_LIO_LIEarly stages of spreading can be explained in terms of SIR standard model, considering that reported cases accounts for the removed individuals, with algebraic growing (sub-exponential) in most locations.\nC_LIO_LIWorldwide, we observe two classes of epidemic growth: sub-exponential during almost all stages (China and Japan) and exponential on the rest of the countries, following the early stage.\nC_LIO_LIThe exponential growth rates ranges from 0.016day-1 (South Korea) to 0.725day-1 (Brunei) which means 1.6% to 107% of new cases per day, for the different countries but China.\nC_LI","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20039594","title":"Covid-19 health care demand and mortality in Sweden in response to non-pharmaceutical (NPIs) mitigation and suppression scenarios","authors":"Rocklov, J.","author_corresponding":"Joacim Rocklov","author_corresponding_institution":"Umea University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039594.source.xml","abstract":"BackgroundWhile the COVID-19 outbreak in China now appears surpressed, Europe and the US have become the epicenters, both reporting many more deaths than China. Responding to the pandemic, Sweden has taken a different approach aiming to mitigate, not suppressing community transmission, by using physical distancing without lock-downs. Here we contrast consequences of different responses to COVID-19 within Sweden, the resulting demand for care, intensive care, the death tolls, and the associated direct healthcare related costs.\n\nMethodsWe use an age stratified health-care demand extended SEIR compartmental model calibrated to the municipality level for all municipalities in Sweden, and a radiation model describing inter-municipality mobility.\n\nResultsOur model fit well with the observed deaths in Sweden up to 20th of April, 2020. The intensive care unit (ICU) demand is estimated to reach almost 10,000 patients per day by early May in an unmitigated scenario, far above the pre-pandemic ICU capacity of 526 beds. In contrast, a scenario with moderate physical distancing and shielding of elderly in combination with more effective isolation of infectious individuals would reduce numbers to below 500 per day. This would substantially flatten the curve, extend the epidemic period, but a risk resurgence is expected if measures are relaxed. The different scenarios show quite different death tolls up to the 1th of September, ranging from 5,000 to 41,000 deaths, exluding deaths potentially caused by ICU shortage. Further, analyses of the total all-cause mortality in Stockholm indicate that a confirmed COVID-19 death is associated with a additional 0.40 (95% Cl: 0.24, 0.57) all-cause death.\n\nConclusionThe results of this study highlight the impact of different combinations of non-pharmaceutical interventions, especially moderate physical distancing and shielding of elderly in combination with more effective isolation of infectious individuals, on reducing deaths and lower healthcare costs. In less effective mitigation scenarios, the demand on ICU beds would rapidly exceed capacity, showing the tight interconnection between the healthcare demand and physical distancing in the society. These findings have relevance for Swedish policy and response to the COVID-19 pandemic and illustrate the importance of maintaining the level of physical distancing for a longer period to suppress or mitigate the impacts from the pandemic.\n\nKey messagesO_LIWe find physical distancing and isolation of infectious individuals without lockdown is effective in mitigating much of the negative direct health impact from the COVID-19 pandemic in Sweden, but has a higher death toll compared to other Scandinavian countries who did implement a lockdown\nC_LIO_LIBetween the start of the Swedish model of physical distancing and shiedling the elderly in March to late April, it appears Sweden has managed to ensure that ICU demands do not exceed ICU capacities and that deaths are substantially reduced compared to a counterfactual scenario.\nC_LIO_LIIn the counterfactual scenario (eg no public health interventions), the intensive care unit demand is estimated to be almost 20 times higher than the intensive care capacity in Sweden and the number of deaths would be between 40,000 to 60,000\nC_LIO_LIUnder current mitigation strategies, the death toll, health care need, and its associated cost are, however, still substantial, and it is likely to continue to rise unless the virus is suppressed, or eliminated. In the stronger mitigation and suppression scenarios, including the scenario fitting best to data from Sweden by late April 2020, there is an obvious risk of resurgence of the epidemic unless physical distancing, shielding of the elderly, and home isolation are effectively sustained.\nC_LIO_LIAdditional analyses indicate all-cause non COVID-19 excess mortality rises with 0.4 deaths per every reported COVID-19 death in the Stockholm area.\nC_LI","published":"10.1093\/ije\/dyaa121","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20032532","title":"Geo temporal distribution of 1,688 Chinese healthcare workers infected with COVID-19 in severe conditions, a secondary data analysis","authors":"Gao, W.; Sanna, M.; Wen, C. P.","author_corresponding":"Wayne Gao","author_corresponding_institution":"Taipei Medical University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20032532.source.xml","abstract":"IntroductionThe COVID-19 outbreak is posing an unprecedented challenge to healthcare workers. This study analyzes the geo-temporal effects on disease severity for the 1,688 Chinese healthcare workers infected with COVID-19.\n\nMethodUsing the descriptive results recently reported by the Chinese CDC, we compare the percentage of infected healthcare workers in severe conditions over time and across three areas in China, and the fatality rate of infected healthcare workers with all the infected individuals in China aged 22-59 years.\n\nResultsAmong the infected Chinese healthcare workers whose symptoms onset appeared during the same ten-day period, the percentage of those in severe conditions decreased statistical significantly from 19.7% (Jan 11 - 20) to 14.4% (Jan 21 - 31) to 8.7% (Feb 1 - 11). Across the country, there was also a significant difference in the disease severity among patients symptoms onset during the same period, with Wuhan being the most severe (17%), followed by Hubei Province (10.4%), and the rest of China (7.0%). The case fatality rate for the 1,688 infected Chinese healthcare workers was significantly lower than that for the 29,798 infected patients aged 20-59 years--0.3% (5\/1,688) vs. 0.65% (193\/29,798), respectively.\n\nConclusionThe disease severity improved considerably over a short period of time in China. The more severe conditions in Wuhan compared to the rest of the country may be attributable to the draconian lockdown. The clinical outcomes of infected Chinese healthcare workers may represent a more accurate estimation of the severity of COVID-19 for those who have access to quality healthcare.","published":"10.1371\/journal.pone.0233255","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20039404","title":"Healthcare worker absenteeism, child care costs, and COVID-19 school closures: a simulation analysis","authors":"Chin, E. T.; Huynh, B. Q.; Lo, N. C.; Hastie, T.; Basu, S.","author_corresponding":"Benjamin Q Huynh","author_corresponding_institution":"Stanford University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039404.source.xml","abstract":"BackgroundSchool closures have been enacted as a measure of mitigation during the ongoing COVID-19 pandemic. It has been shown that school closures could cause absenteeism amongst healthcare workers with dependent children, but there remains a need for spatially granular analyses of the relationship between school closures and healthcare worker absenteeism to inform local community preparedness.\n\nMethodsWe provide national- and county-level simulations of school closures and unmet child care needs across the United States. We develop individual simulations using county-level demographic and occupational data, and model school closure effectiveness with age-structured compartmental models. We perform multivariate quasi-Poisson ecological regressions to find associations between unmet child care needs and COVID-19 vulnerability factors.\n\nResultsAt the national level, we estimate the projected rate of unmet child care needs for healthcare worker households to range from 7.5% to 8.6%, and the effectiveness of school closures to range from 3.2% (R0 = 4) to 7.2% (R0 = 2) reduction in fewer ICU beds at peak demand. At the county-level, we find substantial variations of projected unmet child care needs and school closure effects, ranging from 1.9% to 18.3% of healthcare worker households and 5.7% to 8.8% reduction in fewer ICU beds at peak demand (R0 = 2). We find significant positive associations between estimated levels of unmet child care needs and diabetes prevalence, county rurality, and race (p < 0.05). We estimate costs of absenteeism and child care and observe from our models that an estimated 71.1% to 98.8% of counties would find it less expensive to provide child care to all healthcare workers with children than to bear the costs of healthcare worker absenteeism during school closures.\n\nConclusionsSchool closures are projected to reduce peak ICU bed demand, but could disrupt healthcare systems through absenteeism, especially in counties that are already particularly vulnerable to COVID-19. Child care subsidies could help circumvent the ostensible tradeoff between school closures and healthcare worker absenteeism.","published":"10.1186\/s12916-020-01692-w","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20039537","title":"The Population Attributable Fraction (PAF) of cases due to gatherings and groups with relevance to COVID-19 mitigation strategies","authors":"Brooks-Pollock, E.; Read, J. M.; House, T.; Medley, G.; Keeling, M. J.; Danon, L.","author_corresponding":"Ellen Brooks-Pollock","author_corresponding_institution":"University of Bristol","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039537.source.xml","abstract":"BackgroundMany countries have banned groups and gatherings as part of their response to the pandemic caused by the coronavirus, SARS-CoV-2. Although there are outbreak reports involving mass gatherings, the contribution to overall transmission is unknown.\n\nMethodsWe used data from a survey of social contact behaviour that specifically asked about contact with groups to estimate the Population Attributable Fraction (PAF) due to groups as the relative change in the Basic Reproduction Number when groups are prevented.\n\nFindingsGroups of 50+ individuals accounted for 0.5% of reported contact events, and we estimate that the PAF due to groups of 50+ people is 5.4% (95%CI 1.4%, 11.5%). The PAF due to groups of 20+ people is 18.9% (12.7%, 25.7%) and the PAF due to groups of 10+ is 25.2% (19.4%, 31.4%)\n\nInterpretationLarge groups of individuals have a relatively small epidemiological impact; small and medium sized groups between 10 and 50 people have a larger impact on an epidemic.","published":"10.1098\/rstb.2020.0273","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20039628","title":"Under detection of depression in primary care settings in low and middle-income countries: A systematic review and meta-analysis","authors":"Fekadu, A.; Demissie, M.; Birhane, R.; Medhin, G.; Bitew, T.; Hailemariam, M.; Minaye, A.; Habtamu, K.; Milkias, B.; Petersen, I.; Patel, V.; Cleare, A. J.; Mayston, R.; Thornicroft, G.; Alem, A.; Hanlon, C.; Prince, M.","author_corresponding":"Abebaw Fekadu","author_corresponding_institution":"Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia; Department of Psychiatry, ","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039628.source.xml","abstract":"ObjectiveDepression is the commonest mental disorder in primary care but is poor identified. The objective of this review was to determine the level of detection of depression by primary care clinicians and its determinants in studies from low-and middle-income countries (LMICs).\n\nMethods\n\nDesignSystematic review and meta-analysis. Review protocol was registered in the PROSPERO database (CRD42016039704).\n\nDatabasesPubMed, PsycINFO, Medline, EMBASE, LILAC and AJOL.\n\nQuality assessmentRisk of bias within studies evaluated with the Effective Public Health Practice Project (EPHPP).\n\nSynthesis\"Gold standard\" diagnosis for the purposes of this review were based on the 9-item Patient Health Questionnaire (PHQ-9; cutoff scores of 5 and 10), structured interview or expert diagnosis. Meta-analysis was conducted excluding studies on special populations. Analysis of pooled data were stratified by diagnostic approaches.\n\nResultsA total of 2223 non-duplicate publications were screened. Ten publications, from two multi-country studies and eight single country studies, making 18 country level reports, were included. One of the multi-country studies used an enriched sample of screen positive participants. Overall methodological quality of the studies was good. Depression detection was 0.0% in five reports and <12% in another five. The pooled detection for two reports that used PHQ-9 at a cutoff point of 5 (combined sample size = 1426) was 3.9% (95% CI = 2.3%, 5.5%); in the four reports that used PHQ-9 cutoff score of 10 (combined sample size =5481), the pooled detection was 7.0% (95% CI = 3.9%, 10.2%). For the enriched sample, the pooled detection was 43.5 % (95% CI: 25.7%, 61.0%). Severity of depression and suicidality were significantly associated with detection.\n\nConclusionsThe extremely low detection of depression by primary care clinicians poses a serious threat to scaling up mental healthcare in LMICs. Interventions to improve detection should be prioritized.\n\nStrength and limitation of study{blacktriangleright} This is the first review of detection of depression in LMIC settings\n{blacktriangleright}The review was comprehensive in terms of databases searched\n{blacktriangleright}Screening tools were used as gold standards, which may lead to overestimation of prevalence and underestimation of detection\n{blacktriangleright}The small number of studies and the use of different instruments and cutoff\n{blacktriangleright}points precluded exploration of sources of heterogeneity\n{blacktriangleright}The review does not include studies on distress or sub-threshold depression","published":"10.1186\/s13643-022-01893-9","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20039602","title":"A Tempo-geographic Analysis of Global COVID-19 Epidemic Outside of China","authors":"Liao, H.; Marley, G.; Si, Y.; Wang, Z.; Xie, Y.; Wang, C.; Tang, W.","author_corresponding":"Weiming Tang","author_corresponding_institution":"Dermatology Hospital, Southern Medical University, and the University of North Carolina at Chapel Hill Project-China","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039602.source.xml","abstract":"BackgroundUnderstanding the global epidemic trends, geographic distribution, and transmission patterns of COVID-19 contribute to providing timely information for the global response of the epidemic. This study aims to understand the global pandemic geospatial patterns and trends and identify new epicenters requiring urgent attention.\n\nMethodsData on COVID-19 between 31st Dec. 2019 and 14th Mar. 2020 was included. The epidemic trend was analyzed using joinpoint regressions; the growth of affected countries was by descriptive analysis; and the global distribution and transmission trend by spatial analysis. Findings: The number of new cases in the regions outside of China slowly increased before 24th Feb. and rapidly accelerated after 24th Feb. Compared to China, other affected countries experienced a longer duration of a slow increase at the early stage and rapid growth at the latter stages. The first apparent increase in the number of affected countries occurred from 23rd Jan to 1st Feb, and the second apparent increase started from 25th Feb. The fist COVID-19 cases reported by countries from 28th Feb. were mainly imported from Europe. The geographic distribution changed from single-center (13th Jan. - 20th Feb.) to multi-centers pattern (20th Feb. - 14th Mar.). More countries were affected with COVID-19 and developed local transmission.\n\nInterpretationThe joinpoint regression and geospatial analysis indicated a multi-center pandemic of COVID-19. Strategies to prevent the new multiple centers as well as prevent ongoing transmission are needed.\n\nFundingNIH.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20039149","title":"Prostatic Peripheral Zone Thickness: What is Normal on Magnetic Resonance Imaging?","authors":"Wasserman, N. F.; Spilseth, B.; Sanghvi, T.","author_corresponding":"Neil F Wasserman","author_corresponding_institution":"University of Minnesota","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"radiology and imaging","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20039149.source.xml","abstract":"PurposeTo report the precision of a technique of measuring the PZ thickness on T2-weighted MRI and report normal parameters in patients with normal-sized prostates. We also wanted to establish the mean and second standard deviations (2SD) above and below the mean as criteria for abnormally narrow or expanded PZ thickness.\n\nMethodsOf the initial 1566 consecutive cohort referred for evaluation for carcinoma based on elevated PSA (prostate specific antibody) or DRE (digital rectal examination), 132 separate subjects with normal-sized prostates were selected for this study. Mean age was 58.2 years (15-82). Median serum PSA was 6.2ng\/ML (range, 0.3-145). Most were asymptomatic for lower urinary tract symptoms (LUTS). Inclusion criteria in this study required technically adequate T2-weighted MRI and total prostatic volume (TPV) [&le;] 25 cc. Exclusion criteria included post prostatic surgical and radiation patients, patients having had medical management or minimally invasive therapy for BPH, those being treated for prostatitis. Patients with suspected tumor expanding or obscuring measurement boundaries were also not considered. Transition zone (TZ) and peripheral zone (PZ) volumes were determined using the prolate ellipsoid model. Postero-lateral measurement of the PZ was obtained at the axial level of maximal transverse diameter of the prostate on a line drawn from the outer boundary of the TZ to the inner boundary of the external prostatic capsule. The data was normally distributed. Therefore, it was analyzed using the 2-sided student t-test and Pearson produce correlation statistic.\n\nResultsMean pooled (composite) measurement for the postero-lateral PZ (PLPZ) was 10 mm (CI= 9.5-10.5 mm) with SD of 2.87 mm. Means were statistically the same for the 2 observers (p=0.75). Pearson correlation between the two observers was 0.63.\n\nConclusionsIn a prostate [&le;] 25 cc volume the postero-lateral PZ should be no thicker than 15.8 mm and averages 10.0 mm. when measured in the maximal axial plane on MRI. These norms were independent of age or use of endorectal coil. The technique measurement demonstrated clinically useful precision.","published":"10.1007\/s00261-020-02650-z","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20038455","title":"ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19","authors":"Leung, J. M.; Yang, C. X.; Tam, A.; Shaipanich, T.; Hackett, T. L.; Singhera, G. K.; Dorscheid, D. R.; Sin, D. D.","author_corresponding":"Don D Sin","author_corresponding_institution":"University of British Columbia (UBC) Centre for Heart Lung Innovation","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"respiratory medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038455.source.xml","abstract":"IntroductionCoronavirus disease 2019 (COVID-19) is a respiratory infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus uses the angiotensin converting enzyme II (ACE-2) as the cellular entry receptor to infect the lower respiratory tract. Because individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of severe COVID-19, we determined whether ACE-2 expression in the lower airways was related to COPD and cigarette smoking.\n\nMethodsUsing RNA-seq, we determined gene expression levels in bronchial epithelia obtained from cytologic brushings of 6th to 8th generation airways in individuals with and without COPD. We eternally validated these results from two additional independent cohorts, which used microarray technologies to measure gene expression levels from 6th to 12th generation airways.\n\nResultsIn the discovery cohort (n=42 participants), we found that ACE-2 expression levels were increased by 48% in the airways of COPD compared with non-COPD subjects (COPD=2.52{+\/-}0.66 log2 counts per million reads (CPM) versus non-COPD= 1.70{+\/-}0.51 CPM, p=7.62x10-4). There was a significant inverse relationship between ACE-2 gene expression and FEV1% of predicted (r=-0.24; p=0.035). Current smoking also significantly increased ACE-2 expression levels compared with never smokers (never current smokers=2.77{+\/-}0.91 CPM versus smokers=1.78{+\/-}0.39 CPM, p=0.024). These findings were replicated in the two eternal cohorts.\n\nConclusionsACE-2 expression in lower airways is increased in patients with COPD and with current smoking. These data suggest that these two subgroups are at increased risk of serious COVID-19 infection and highlight the importance of smoking cessation in reducing the risk.","published":"10.1183\/13993003.00688-2020","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038414","title":"State Laws and Regulations Addressing Nurse-Initiated Protocols and Use of Nurse-Initiated Protocols in Emergency Departments: A Mixed-methods Cross-sectional Survey Study","authors":"Castner, J.; Boris, L.","author_corresponding":"Jessica Castner","author_corresponding_institution":"Castner Incorporated","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"nursing","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038414.source.xml","abstract":"IntroductionState regulations may impede the use of nurse-initiated protocols to begin life-saving treatments when patients arrive to the emergency department. In crowding and small-scale disaster events, this could translate to life and death practice differences. Nevertheless, research demonstrates nurses do utilize nurse-initiated protocols despite legal prohibitions. The purpose of this study was to explore the relationship of the state regulatory environment as expressed in nurse practice acts and interpretive statements prohibiting the use of nurse-initiated protocols with hospital use of nurse-initiated protocols in emergency departments.\n\nMethodsA mixed-methods approach was used with a cross-sectional nationwide survey. The independent variable categorized the location of the hospital in states that have a protocol prohibition. Outcomes included protocols for blood laboratory tests, x-rays, over the counter medication, and electrocardiograms. A second analysis was completed with New York State alone because this state has the strongest language prohibiting nurse-initiated protocols.\n\nResults350 surveys from 48 states and the District of Columbia were received. A hospital was more likely to have policies supporting nurse-initiated protocols if they were not in a state with scope of practice prohibitions. Four qualitative categories emerged: advantages, approval, prohibition, and conditions under which protocols can be used. Prohibitive language was associated with less protocol use for emergency care.\n\nConclusionState scope of practice inconsistencies create misalignment with emergency nurse education and training, which may impede timely care and contribute to inequalities and inefficiencies in emergency care. In addition, prohibitive language places practicing nurses responding to emergencies in crowded work environments at risk.","published":"10.1177\/1527154420954457","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20038885","title":"Early Outcomes of Preoperative 5-fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection","authors":"Parsai, S.; Lawrenz, J.; Kilpatrick, S.; Rubin, B.; Hymes, C.; Gray, M.; Mesko, N.; Shah, C.; Nystrom, L.; Scott, J. G.","author_corresponding":"Jacob G Scott","author_corresponding_institution":"Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 10201 Carnegie Ave, Cleveland, OH 44195, USA","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038885.source.xml","abstract":"Purpose\/ObjectivesThere are limited data regarding the use of hypofractionated radiation therapy (RT) for soft tissue sarcoma. We report early oncologic outcomes and wound complications of patients undergoing preoperative hypofractionated (5 fraction) RT followed by immediate surgical resection.\n\nMaterials\/MethodsAn IRB-approved database of patients treated with preoperative RT for soft tissue sarcoma was queried. Patients treated with a hypofractionated dosing regimen followed by immediate (within 7 days) planned wide surgical resection were identified.\n\nResultsBetween 2016 to 2019, sixteen patients met eligibility criteria. The median clinical follow-up was 10.7 months (range 1.7-33.2). The median patient age was 64 years old (range 33-88). Ten of the sarcomas were located in the lower extremity, 4 in the upper extremity, and two were located in the trunk. Five patients had metastatic disease at diagnosis. The majority of the patients received a total radiation dose of 30 Gy in 5 fractions (range 27.5-40 Gy) on consecutive days. All patients were planned with IMRT\/VMAT. The median time to surgical resection following the completion of RT was 1 day (range 0-7 days). The median time from initial biopsy results to completion of primary oncologic therapy was 20 days (range 16-35). Ten patients achieved R0 resection, whereas the remaining 6 patients achieved R1 resection. Of the 13 patients assessed for local control, no patients developed local failure. Five patients developed wound healing complications (31%), of which only three patients (19%) required return to the operating room.\n\nConclusionsTreatment of soft tissue sarcoma with preoperative hypofractionated RT followed by immediate resection resulted in a median of 20 days from biopsy results to completion of oncologic therapy. Early outcomes demonstrate favorable wound healing. Further prospective data with long-term follow-up is required to determine the oncologic outcomes and toxicity of hypofractionated preoperative RT.","published":"10.1016\/j.adro.2020.06.024","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20037960","title":"The contribution of X-linked coding variation to severe developmental disorders","authors":"Martin, H. C.; Gardner, E. J.; Samocha, K. E.; Kaplanis, J.; Akawi, N.; Sifrim, A.; Eberhardt, R. Y.; Taylor Tavares, A. L.; Neville, M. D.; Niemi, M. E. K.; Gallone, G.; McRae, J.; Wright, C. F.; FitzPatrick, D. R.; Firth, H. V.; Hurles, M. E.","author_corresponding":"Hilary C Martin","author_corresponding_institution":"Wellcome Sanger Institute","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20037960.source.xml","abstract":"Over 130 X-linked genes have been robustly associated with developmental disorders (DDs), and X-linked causes have been hypothesised to underlie the higher DD rates in males. We evaluated the burden of X-linked coding variation in 11,046 DD patients, and found a similar rate of X-linked causes in males and females (6.0% and 6.9%, respectively), indicating that such variants do not account for the 1.4-fold male bias. We developed an improved strategy to detect novel X-linked DDs and identified 23 significant genes, all of which were previously known, consistent with our inference that the vast majority of the X-linked burden is in known DD-associated genes. Importantly, we estimated that, in male probands, only 13% of inherited rare missense variants in known DD-associated genes are likely to be pathogenic. Our results demonstrate that statistical analysis of large datasets can refine our understanding of modes of inheritance for individual X-linked disorders.","published":"10.1038\/s41467-020-20852-3","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20038505","title":"The general impact of haploinsufficiency on brain connectivity underlies the pleiotropic effect of neuropsychiatric CNVs","authors":"Moreau, C.; Huguet, G.; Urchs, S.; Douard, E. A.; Sharmarke, H.; Orban, P.; Labbe, A.; Modenato, C.; Martin-Brevet, S.; Kuldeep, K.; Martin, C.-O.; Jizi, K.; Younis, N.; Tamer, P.; Martineau, J.-L.; Silva, A. I.; Jonch, A. E.; Lin, A.; Simons VIP Foundation,  ; Hall, J.; van den Bree, M. B.; Owen, M. J.; Linden, D. E.; Maillard, A.; Lippe, S.; Greenwood, C. M.; Bearden, C. E.; Thompson, P. M.; Bellec, P.; Jacquemont, S.","author_corresponding":"Clara Moreau","author_corresponding_institution":"Research Center of the UHC of Sainte Justine, University of Montreal","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038505.source.xml","abstract":"Copy number variants (CNVs) are among the most highly penetrant genetic risk factors for neuropsychiatric disorders. Their impact on brain connectivity remains mostly unstudied. Because they confer risk for overlapping conditions, we hypothesized that they may converge on shared connectivity patterns.\n\nWe performed connectome-wide analyses using resting-state functional MRI data from 436 carriers of neuropsychiatric CNVs at the 1q21.1, 15q11.2, 16p11.2, 22q11.2 loci, 4 \"neutral effect\" CNVs, 66 carriers of scarcer neuropsychiatric CNVs, 756 individuals with idiopathic autism spectrum disorder (ASD), schizophrenia, attention deficit hyperactivity disorder, and 5,377 controls. Neuropsychiatric CNVs showed global shifts of mean connectivity. The effect size of CNVs on relative connectivity (adjusted for the mean) was correlated with the known level of neuropsychiatric risk conferred by CNVs. Individuals with idiopathic schizophrenia and ASD had similarities in connectivity with neuropsychiatric CNVs. We reported a linear relationship between connectivity and intolerance to haploinsufficiency measured for all genes encompassed by CNVs across 18 loci. This profile involved the thalamus, the basal ganglia, somatomotor and frontoparietal networks and was correlated with lower general intelligence and higher autism severity scores. An exploratory factor analysis confirmed the contribution of these regions to three latent components shared across CNVs and neuropsychiatric disorders.\n\nWe posit that deleting genes intolerant to haploinsufficiency reorganize connectivity along general dimensions irrespective of where deletions occur in the genome. This haploinsufficiency brain signature opens new avenues to understand polygenicity in psychiatric conditions and the pleiotropic effect of CNVs on cognition and risk for neuropsychiatric disorders.\n\nOne sentence summaryNeuropsychiatric CNVs across the genome reorganize brain connectivity architecture along dominant patterns contributing to complex idiopathic conditions.","published":"10.1016\/j.biopsych.2021.02.115","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038364","title":"Supervised Machine Learning for the Early Prediction of Acute Respiratory Distress Syndrome (ARDS)","authors":"Le, S.; Pellegrini, E.; Green-Saxena, A.; Summers, C.; Hoffman, J.; Calvert, J.; Das, R.","author_corresponding":"Abigail Green-Saxena","author_corresponding_institution":"Dascena Inc., Oakland, CA, United States","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038364.source.xml","abstract":"PurposeAcute respiratory distress syndrome (ARDS) is a serious respiratory condition with high mortality and associated morbidity. The objective of this study is to develop and evaluate a novel application of gradient boosted tree models trained on patient health record data for the early prediction of ARDS.\n\nMaterials and Methods9919 patient encounters were retrospectively analyzed from the Medical Information Mart for Intensive Care III (MIMIC-III) data base. XGBoost gradient boosted tree models for early ARDS prediction were created using routinely collected clinical variables and numerical representations of radiology reports as inputs. XGBoost models were iteratively trained and validated using 10-fold cross validation.\n\nResultsOn a hold-out test set, algorithm classifiers attained area under the receiver operating characteristic curve (AUROC) values of 0.905, 0.827, 0.810, and 0.790 when tested for the prediction of ARDS at 0-, 12-, 24-, and 48-hour windows prior to onset, respectively.\n\nConclusionSupervised machine learning predictions may help predict patients with ARDS up to 48 hours prior to onset.","published":"10.1016\/j.jcrc.2020.07.019","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038752","title":"Bibliometric Analysis of Global Scientific Research on SARSCoV-2 (COVID-19)","authors":"Rafiei Nasab, F.; rahim, F.","author_corresponding":"Fakher rahim","author_corresponding_institution":"Ahvaz Jundishapur University of Medical Sciences","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038752.source.xml","abstract":"Background and AimSince late 2019, an unknown-origin pneumonia outbreak detected in Wuhan city, Hubei Province, China. We aimed to build a model to qualitatively and quantitatively assess publications of research of COVID-19 from 2019 to 2020.\n\nMaterials and MethodsData were obtained from the Web of Science (WOS), PubMed, and Scopus Core Collection on March 02, 2020, and updated on March 10. We conducted a qualitative and quantitative analysis of publication outputs, journals, authors, institutions, countries, cited references, keywords, and terms according to bibliometric methods using VOS viewer c software packages.\n\nResultsInitially, we identified 227 papers, of which after an exclusion process, 92 studies were selected for statistical analyses. China accounted for the highest proportion of published research (44 papers, 40.48%), followed by the United States (21 papers, 19.32%), and Canada (7 papers, 6.44%). Adjusted by gross domestic product (GDP), ranked first, with 0.003 articles per billion GDP. In total, the top 10 journals published 47 articles, which accounted for 51.08% of all publications in this Feld. A total of 6 studies (05.52%) were supported by National Natural Science Foundation of China. Chinese Academy of Sciences ranked second 2, 2.76%).\n\nConclusionBibliometric and visualized mapping may quantitatively monitor research performance in science and present predictions. The subject of this study was the fast growing publication on COVID-19. Most studies are published in journals with very high impact factors (IFs) and other journals are more interested in this type of research.\n\nHighlightsO_LIBibliometric description and mapping provided a birds-eye view of information on Covid-19 related research\nC_LIO_LIReaders to comprehend the history of published Covid-19 articles in just a few minutes.\nC_LIO_LIWe evaluated the research strength of countries and institutions,\nC_LIO_LIScholars might refer to in order to find cooperative institutions.\nC_LIO_LIDuring our research using the selected database, we tried to guarantee comprehension and objectivity.\nC_LI","published":"10.22074\/cellj.2021.7794","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20038257","title":"CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models","authors":"Leon-Triana, O.; Sabir, S.; Calvo, G. F.; Belmonte-Beitia, J.; Chulian, S.; Martinez-Rubio, A.; Rosa, M.; Perez-Martinez, A.; Ramirez-Orellana, M.; Perez-Garcia, V.","author_corresponding":"Odelaisy Le\u00f3n-Triana","author_corresponding_institution":"University of Castilla-La Mancha","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"hematology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038257.source.xml","abstract":"Immunotherapies use components of the patient immune system to selectively target cancer cells. The use of CAR T cells to treat B-cell malignancies - leukaemias and lymphomas- is one of the most successful examples, with many patients experiencing long-lasting complete responses to this therapy. This treatment works by extracting the patients T cells and adding them the CAR group, which enables them to recognize and target cells carrying the antigen CD19+, that is expressed in these haematological tumors.\n\nHere we put forward a mathematical model describing the time response of leukaemias to the injection of CAR T-cells. The model accounts for mature and progenitor B-cells, tumor cells, CAR T cells and side effects by incorporating the main biological processes involved. The model explains the early post-injection dynamics of the different compartments and the fact that the number of CAR T cells injected does not critically affect the treatment outcome. An explicit formula is found that provides the maximum CAR T cell expansion in-vivo and the severity of side effects. Our mathematical model captures other known features of the response to this immunotherapy. It also predicts that CD19+ tumor relapses could be the result of the competition between tumor and CAR T cells analogous to predator-prey dynamics. We discuss this fact on the light of available evidences and the possibility of controlling relapses by early re-challenging of the tumor with stored CAR T cells.","published":"10.1016\/j.cnsns.2020.105570","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20038778","title":"Clinical characteristics and reasons of different duration from onset to release from quarantine for patients with COVID-19 Outside Hubei province, China.","authors":"Tian, S.; Chang, Z.; Wang, Y.; Wu, M.; Zhang, W.; Zhou, G.; Zou, X.; Tian, H.; Xiao, T.; Xing, J.; Chen, J.; Han, J.; Ning, K.; Wu, T.","author_corresponding":"Suochen Tian","author_corresponding_institution":"1.\tDepartment of Intensive Care Unit, Liaocheng people\\'s hospital, Liaocheng, Shandong, 252000, China","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20038778.source.xml","abstract":"ObjectiveTo find out more characteristics and rules of COVID-19 by analyzing the clinical course of COVID-19 patients in a region outside Hubei province.\n\nMethods37 cases diagnosed adult COVID-19 cases of general characteristics, history of epidemiology, chronic underlying diseases, clinical symptoms and complications, chest CT, biochemical monitoring, severity assessment, treatment and outcome were retrospectively analyzed, and according to the duration from onset to release from quarantine were divided into [&le;]20 -day group and > 20 -day group, compare the similarities and differences between the two groups.\n\nResultsAmong the 37 patients, 5 were mild, 30 were moderate, 1 was severe and 1 was critical. All the patients were released from quarantine without death. The average duration from onset to release from quarantine was 20.2{+\/-}6.6 days, The average length of stay from onset to hospitalization was 4.1{+\/-}3.7 days, and hospitalization duration average 16.1 {+\/-}6.2 days. The average age was 44.3{+\/-}1.67 years. 78.4% of cases were caused by exposure to a confirmed patient or the workplace of a confirmed patient. The main symptoms were cough (67.6%), fever (62.2%), shortness of breath (32.4%), fatigue (24.3%), sore throat (21.6%,) vomiting or diarrhea (21.6%). The white blood cell count was decreased in 27.0% of the patients, and the lymphocyte count was decreased in 62.2% of the patients, of which 43.5% patients were [&le;]0.6x109\/L. On admission, 86.5% of patients with chest CT showed pneumonia, including some asymptomatic patients. 68.8% of patients showed bilateral infiltration. In the > 20-day group, the average age was 49.9{+\/-}1.38 years old, and the duration from onset to hospitalization was 5.5{+\/-}3.9 days. Compared with the [&le;] 20-day group, the age was older and duration was longer, P < 0.05. All the 7 asymptomatic patients were [&le;]20 -day group. When 37 patients were released from quarantine, the white blood cell count of 16.2% patients was < 4.0x109\/L, and the lymphocyte count of 59.5% patients was <1.1x109\/L, and the absolute count of white blood cells and lymphocytes was 5.02{+\/-}1.3 4x109\/L and 1.03{+\/-}0.34x109\/L respectively, compared with those on admission, P > 0.05.\n\nConclusionThe majority of COVID-19 cases in the study area were mild and moderate, with good clinical outcomes. There were some special characteristics in the clinical process. The reasons of duration from onset to release from quarantine were complex. There was no significant change in the number of granulocytes at the time of release from quarantine compared to the time of admission.","published":"10.3389\/fmed.2020.00210","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040444","title":"From a single host to global spread. The global mobility based modelling of the COVID-19 pandemic implies higher infection and lower detection rates than current estimates.","authors":"Siwiak, M. M.; Szczesny, P.; Siwiak, M. P.","author_corresponding":"Marian P Siwiak","author_corresponding_institution":"Data 3.0","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20040444.source.xml","abstract":"BackgroundSince the outbreak of the COVID-19 pandemic, multiple efforts of modelling of the geo-temporal transmissibility of the virus have been undertaken, but none describes the pandemic spread at the global level. The aim of this research is to provide a high-resolution global model of the pandemic that overcomes the problem of biased country-level data on the number of infected cases. To achieve this we propose a novel SIR-type metapopulation transmission model and a set of analytically derived model parameters. We used them to perform a simulation of the disease spread with help of the Global Epidemic and Mobility (GLEAM) framework embedding actual population densities, commute patterns and long-range travel networks. The simulation starts on Nov 17th, 2019 with just a single pre-symptomatic, yet infectious, case in Wuhan, China, and results in an accurate prediction of the number of diagnosed cases after 154 days in multiple countries across five continents. In addition, the model outcome shows high compliance with the results of a random screening test conducted on pregnant women in the New York area.\n\nMethodsWe have built a modified SIR metapopulation transmission model and parameterized it analytically either by setting the values of the parameters based on the literature, or by assuming their plausible values. We compared our results with the number of diagnosed cases in twenty selected countries which provide reliable statistics but differ substantially in terms of strength and speed of undertaken Non-Drug Interventions. The obtained 95% confidence intervals for the predictions are in agreement with the empirical data.\n\nResultsThe parameters that successfully model the pandemic are: the basic reproduction number R0, 4.4; a latent non-infectious period of 1.1. days followed by 4.6 days of the presymptomatic infectious period; the probability of developing severe symptoms, 0.01; the probability of being diagnosed when presenting severe symptoms of 0.6; the probability of diagnosis for cases with mild symptoms or asymptomatic, 0.001.\n\nDiscussionParameters that successfully reproduce the observed number of cases indicate that both R0 and the prevalence of the virus might be underestimated. This is in concordance with the newest research on undocumented COVID-19 cases. Consequently, the actual mortality rate is putatively lower than estimated. Confirmation of the pandemic characteristic by further refinement of the model and screening tests is crucial for developing an effective strategy for the global epidemiological crisis.","published":"10.7717\/peerj.9548","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20038422","title":"Estimating the reproduction number of COVID-19 in Iran using epidemic modeling","authors":"Sahafizadeh, E.; Sartoli, S.","author_corresponding":"Ebrahim Sahafizadeh","author_corresponding_institution":"Payame Noor University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038422.source.xml","abstract":"BackgroundAs reported by Iranian governments, the first cases of coronavirus (COVID-19) infections confirmed in Qom, Iran on February 19, 2020 (30 Bahman 1398). The number of identified cases afterward increased rapidly and the novel coronavirus spread to all provinces of the country. This study aimed to fit an epidemic model to the reported cases data to estimate the basic reproduction number (R0) of COVID-19 in Iran.\n\nMethodsWe used data from February 21, 2020, to April 21, 2020, on the number of cases reported by Iranian governments and we employed the SIR (Susceptible-Infectious-Removed) epidemic spreading model to fit the transmission model to the reported cases data by tuning the parameters in order to estimate the basic reproduction number of COVID-19 in Iran.\n\nResultsThe value of reproduction number was estimated 4.86 in the first week and 4.5 in the second week. it decreased from 4.29 to 2.37 in the next four weeks. At the seventh week of the outbreak the reproduction number was reduced below one.\n\nConclusionsThe results indicate that the basic reproduction number of COVID-19 was significantly larger than one in the early stages of the outbreak. However, implementing social distancing and preventing travelling on Nowruz (Persian New Year) effectively reduced the reproduction number. Although the results indicate that reproduction number is below one, it is necessary to continue social distancing and control travelling to prevent causing a second wave of outbreak.","published":"10.1093\/jtm\/taaa077","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038315","title":"Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients","authors":"Fu, H.; Xu, H.; Zhang, N.; Xu, H.; Li, Z.; Chen, H.; Xu, R.; Sun, R.; Wen, L.; Xie, L.; Liu, H.; Zhang, K.; Fu, C.; Hou, K.; Yang, Z.; Yang, M.; Guo, Y.","author_corresponding":"Yingkun Guo Sr.","author_corresponding_institution":"Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospi","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038315.source.xml","abstract":"BackgroundSince December 2019, more than 100,000 coronavirus disease 2019 (COVID-19) patients have been confirmed globally based on positive viral nucleic acids with real-time reverse transcriptase-polymerase chain reaction (RT-PCR). However, the association between clinical, laboratory and CT characteristics and RT-PCR results is still unclear. We sought to examine this association in detail, especially in recovered patients.\n\nMethodsWe analysed data from 52 confirmed patients who had been discharged with COVID-19. The clinical, laboratory, and radiological data were dynamically recorded and compared with the admission and follow-up RT-PCR results.\n\nResultsIn this cohort, 52 admitted COVID-19 patients who had confirmed positive RT-PCR results were discharged after 2 rounds of consecutively negative RT-PCR results. Compared with admission levels, CRP levels (median 4.93 mg\/L [IQR: 1.78-10.20]) decreased significantly (p<0.001). and lymphocyte counts (median 1.50x109\/L [IQR: 1.11-1.88]) increased obviously after obtaining negative RT-PCR results (p<0.001). Additionally, substantially improved inflammatory exudation was observed on chest CT except for 2 progressed patients. At the two-week follow-up after discharge, 7 patients had re-positive RT-PCR results, including the abovementioned 2 progressed patients. Among the 7 patients, new GGO was demonstrated in 2 patients. There were no significant differences in CPR levels or lymphocyte counts when comparing the negative and re-positive PCT results (all p >0.05).\n\nConclusionHeterogeneity between CT features and RT-PCR results was found in COVID-19, especially in some recovered patients with negative RT-PCR results. Our study highlights that both RT-PCR and chest CT should be considered as the key determinants for the diagnosis and management of COVID-19 patients.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038539","title":"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China","authors":"Yan, S.; Song, X.; Lin, F.; Zhu, H.; Wang, X.; Li, M.; Ruan, J.; Lin, C.; Liu, X.; Wu, Q.; Luo, Z.; Fu, W.; Chen, S.; Yuan, Y.; Liu, S.; Yao, J.; Lv, C.","author_corresponding":"Chuanzhu Lv","author_corresponding_institution":"The Second Affiliated Hospital of Hainan Medical University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038539.source.xml","abstract":"BackgroundSince January 2020, coronavirus disease 2019 (Covid-19) has spread rapidly and developing the pandemic model around the world. Data have been needed on the clinical characteristics of the affected patients in an imported cases as model in island outside Wuhan.\n\nMethodsWe conducted a retrospective study included all 168 confirmed cases of Covid-19 in Hainan province from 22 January 2020 to 13 March 2020. Cases were confirmed by real-time RT-PCR and were analysed for demographic, clinical, radiological and laboratory data.\n\nResultsOf 168 patients, 160 have been discharged, 6 have died and 2 remain hospitalized. The median age was 51.0 years and 51.8% were females. 129 (76.8%) patients were imported cases, and 118 (70.2%), 51 (30.4%) and 52 (31%) of patients lived in Wuhan or traveled to Wuhan, had contact with Covid-19 patients, or had contact with Wuhan residents, respectively. The most common symptoms at onset of illness were fever (65.5%), dry cough (48.8%) and expectoration (32.1%). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (60.2%). The elderly people with diabetes, hypertension and CVD are more likely to develop severe cases. Follow-up of 160 discharged patients found that 20 patients (12.5%) had a positive RT-PCR test results of pharyngeal swabs or anal swabs or fecal.\n\nConclusionsIn light of the rapid spread of Covid-19 around the world, early diagnosis and quarantine is important to curb the spread of Covid-19 and intensive treatments in early stage is to prevent patients away from critical condition.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20039008","title":"Effectiveness and safety of antiviral or antibody treatments for coronavirus","authors":"Rios, P.; Radhakrishnan, A.; Antony, J.; Thomas, S. M.; Muller, M.; Straus, S. E.; Tricco, A. C.","author_corresponding":"Andrea C. Tricco","author_corresponding_institution":"Li Ka Shing Research Institute, Knowledge Translation Program, St. Michael\\'s Hospital","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039008.source.xml","abstract":"BackgroundTo identify safe and effective medical countermeasures (e.g., antivirals\/antibodies) to address the current outbreak of a novel coronavirus (COVID-19)\n\nMethodsComprehensive literature searches were developed by an experienced librarian for MEDLINE, EMBASE, the Cochrane Library, and biorxiv.org\/medrxiv.org; additional searches for ongoing trials and unpublished studies were conducted in clinicaltrials.gov and the Global Infectious Diseases and Epidemiology Network (GIDEON). Title\/abstract and full-text screening, data abstraction, and risk of bias appraisal were carried out by single reviewers.\n\nResults54 studies were included in the review: three controlled trials, 10 cohort studies, seven retrospective medical record\/database studies, and 34 case reports or series. These studies included patients with severe acute respiratory syndrome (SARs, n=33), middle east respiratory syndrome (MERS, n=16), COVID-19 (n=3), and unspecified coronavirus (n=2). The most common treatment was ribavirin (n=41), followed by oseltamivir (n=10) and the combination of lopinavir\/ritonavir (n=7). Additional therapies included broad spectrum antibiotics (n=30), steroids (n=39) or various interferons (n=12). No eligible studies examining monoclonal antibodies for COVID-19 were identified. One trial found that ribavirin prophylactic treatment statistically significantly reduced risk of MERS infection in people who had been exposed to the virus. Of the 21 studies reporting rates of ICU admission in hospitalized SARS or MERS patients, none reported statistically significant results in favour of or against antiviral therapies. Of the 40 studies reporting mortality rates in hospitalized SARS or MERS patients, one cohort study (MERS) and one retrospective study (SARS) found a statistically significant increase in the mortality rate for patients treated with ribavirin. Eighteen studies reported potential drug-related adverse effects including gastrointestinal symptoms, anemia, and altered liver function in patients receiving ribavirin.\n\nConclusionThe current evidence for the effectiveness and safety of antiviral therapies for coronavirus is inconclusive and suffers from a lack of well-designed prospective trials or observational studies, preventing any treatment recommendations from being made. However, it is clear that the existing body of evidence is weighted heavily towards ribavirin (41\/54 studies), which has not shown conclusive evidence of effectiveness and may cause harmful adverse events so future investigations may consider focusing on other candidates for antiviral therapy.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20037473","title":"Now-casting the COVID-19 epidemic: The use case of Japan, March 2020","authors":"Gloeckner, S.; Krause, G.; Hoehle, M.","author_corresponding":"Stephan Gloeckner","author_corresponding_institution":"Department of Epidemiology, Helmholtz Center for Infection Research","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20037473.source.xml","abstract":"BackgroundReporting delays in disease surveillance impair the ability to assess the current dynamic of an epidemic. In continuously updated epidemic curves, case numbers for the most recent epidemic week or day usually appear to be lower than the previous, suggesting a decline of the epidemic. In reality, the epidemic curve may still be on the rise, because reporting delay prevents the most recent cases to appear in the case count. In context of the COVID-19 epidemic and for countries planning large international gatherings, such as the Summer Olympic Games in Japan 2020, the ability to assess the actual stage of an epidemic is of outmost importance.\n\nMethodsWe applied now-casting onto COVID-19 data provided by the nCoV-2019 Data Working Group to evaluate the true count of cases, by taking into account reporting delays occurring between date of symptom onset and date of confirmation.\n\nFindingsWe calculated a decrease of reporting delay, from a median delay of ten days in calendar week four 2020 to six days in calendar week eight, resulting in an overall mean of 4.3 days. The confidence intervals of the now-casting indicated an increase of cases in the last reporting days, while case country in that same time period suggested a decline.\n\nInterpretationAs a specific use case this tool may be of particular value for the challenging risk assessment and risk communication in the context of the Summer Olympic Games in Japan 2020 and similar situations elsewhere.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038950","title":"A model for COVID-19 prediction in Iran based on China parameters","authors":"Zareie, B.; Roshani, A.; Mansournia, M. A.; Rasouli, M. A.; Moradi, G.","author_corresponding":"Ghobad Moradi","author_corresponding_institution":"Kurdistan University of Medical Sciences","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038950.source.xml","abstract":"BackgroundThe rapid spread of COVID-19 virus from China to other countries and outbreaks of disease require an epidemiological analysis of the disease in the shortest time and an increased awareness of effective interventions. The purpose of this study was to estimate the COVID-19 epidemic in Iran based on the SIR model. The results of the analysis of the epidemiological data of Iran from January 22 to March 8, 2020 were investigated and the prediction was made until March 29, 2020.\n\nMethodsBy estimating the three parameters of time-dependent transmission rate, time-dependent recovery rate, and time-dependent mortality rate from Covid-19 outbreak in China, and using the number of Covid-19 infections in Iran, we predicted the number of patients for the next month in Iran. Each of these parameters was estimated using GAM models. All analyses were conducted in R software using the mgcv package.\n\nFindingsOn average, 925 people with COVID-19 are expected to be infected daily in Iran. The epidemic peaks within one week (15.03.2020 to 03.21.2020) and reaches its highest point on 03.18.2020 with 1126 infected cases.\n\nConclusionThe most important point is to emphasize the timing of the epidemic peak, hospital readiness, government measures and public readiness to reduce social contact.","published":"10.34172\/aim.2020.05","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20038141","title":"Covid-19 dynamics in Albania: first estimates and projections","authors":"Gjini, E.","author_corresponding":"Erida Gjini","author_corresponding_institution":"Instituto Gulbenkian de Ciencia","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038141.source.xml","abstract":"The SARS-CoV-2 epidemic is one of the biggest challenges healthcare systems worldwide have ever had to face. To curb transmission many countries have adopted social distancing measures and travel restrictions. Estimating the effect of these measures in each context is challenging and requires mathematical models of the transmission dynamics. Projections for the future course of the epidemic strongly rely on model predictions and accurate representation of real-time data as they accumulate. Here I develop an SEIR modeling framework for Covid-19, to evaluate reported cases and fatalities, and to enable forecasting using evidence-based Bayesian parameter estimation. This Bayesian framework offers a tool to parametrize real-time dynamics of Covid-19 cases, and explore the effect of control as it unfolds in any setting. I apply the model to Covid-19 data from Albania, where drastic control measures were put in place already on the day of the first confirmed case. Evaluating the dynamics of reported cases 9-31 March 2020, I estimate parameters and make preliminary projections. Three weeks into the measures, Albanian data already indicate a strong signature of more than 40% transmission reduction, and lend support to a progressively increasing effect of control measures rather than a static one. In the Albanian setting, the model and data match well, projecting the peak of the outbreak may be around 5-15 April, and be contained within 300 active confirmed cases if control continues with the same trend. This framework can be used to understand the quantitative effects of different control measures in real-time, and inform adaptive intervention for success in other settings.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038158","title":"Climatic influences on the worldwide spread of SARS-CoV-2","authors":"Bariotakis, M.; Sourvinos, G.; Castanas, E.; Pirintsos, S. A.","author_corresponding":"Stergios A Pirintsos","author_corresponding_institution":"Department of Biology, University of Crete","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038158.source.xml","abstract":"The rapid global spread of the novel, pathogenic, SARS-CoV-2 causing the severe acute respiratory disease COVID-19, becomes a major health problem worldwide and pose the need for international predictive programs. Given the lack of both specific drugs and an efficient preventive vaccine, the expectation that SARS-CoV-2s transmission rate might decrease in temperate regions during summer, dominated the social scene. Here, we attempted a prediction of the worldwide spread of the infections based on climatic data, expressed by 19 bioclimatic variables. The calculated probability maps shown that potential areas of infection follow a shift from the Tropical to Temperate and Mediterranean Bioclimatic regions, and back to the Tropics again. Maps show an increased probability of infections in Europe, followed by an expansion covering areas of the Middle East and Northern Africa, as well as Eastern coastal areas of North America, South-Eastern coastal areas of Latin America and two areas of Southern Australia, and later return to areas of Southeastern Asia, in a manner similar to that of influenza strains (H3N2). Our approach may therefore be of value for the worldwide spread of SARS-CoV-2, suggesting an optimistic scenario of asynchronous seasonal global outbreaks, like other viral respiratory diseases. Consequently, we suggest the incorporation of a climatic impact in the design and implementation of public health policies. Maps of our model are available (constantly updated up to the saturation of the model) at: https:\/\/navaak.shinyapps.io\/CVRisk\/.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20038471","title":"Differentiating the Effect of Medication and Illness on Brain Volume Reductions in First-Episode Psychosis: A Longitudinal, Randomized, Triple-blind, Placebo-controlled MRI study","authors":"Chopra, S.; Fornito, A.; Francey, S.; O'Donoghue, B.; Cropley, V.; Nelson, B.; Graham, J.; Baldwin, L.; Tahtalian, S.; Yuen, H. P.; Allott, K.; Alvarez-Jimenez, M.; Harrigan, S.; Sabaroedin, K.; Pantelis, C.; Wood, S. J.; McGorry, P.","author_corresponding":"Alex Fornito","author_corresponding_institution":"Monash University, Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038471.source.xml","abstract":"Changes in brain volume are a common finding in Magnetic Resonance Imaging (MRI) studies of people with psychosis and numerous longitudinal studies suggest that volume deficits progress with illness duration. However, a major unresolved question concerns whether these changes are driven by the underlying illness or represent iatrogenic effects of antipsychotic medication. Here, we report MRI findings from a triple-blind randomised placebo-controlled study where 62 antipsychotic-naive patients with first episode psychosis (FEP) received either an atypical antipsychotic or a placebo pill over a treatment period of 6 months. Both FEP groups received intensive psychosocial therapy. A healthy control group (n=27) was also recruited. Structural MRI scans were obtained at baseline, 3-months and 12- months. Our primary aim was to differentiate illness-related brain volume changes from medication-related changes within the first 3 months of treatment. We secondarily investigated long-term effects at the 12-month timepoint. From baseline to 3 months, we observed a significant group x time interaction in the pallidum (p < 0.05 FWE-corrected), such that patients receiving antipsychotic medication showed increased volume, patients on placebo showed decreased volume, and healthy controls showed no change. In patients, a greater increase in pallidal grey matter volume over 3 months was associated with a greater reduction in symptom severity. We additionally found preliminary evidence for illness- related volume reductions in prefrontal cortices at 12 months and medication-related volume reductions in cerebellum at both 3-months and 12-months. Our findings indicate that psychotic illness and antipsychotic exposure exert distinct and spatially distributed effects on brain volume. Our results align with prior work in suggesting that the therapeutic efficacy of antipsychotic medications may be primarily mediated through their effects on the basal ganglia.","published":"10.1038\/s41386-021-00980-0","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20037945","title":"Insignificant effect of counter measure for coronavirus infectious disease -19 in Japan","authors":"Sugishita, Y.; Kurita, J.; Sugawara, T.; Ohkusa, Y.","author_corresponding":"Junko Kurita","author_corresponding_institution":"Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Ibaraki, Japan","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20037945.source.xml","abstract":"BackgroundTo control the COVID-19 outbreak in Japan, sports and entertainment events were canceled and schools were closed throughout Japan from February 26 through March 19. That policy has been designated as voluntary event cancellation and school closure (VECSC).\n\nObjectThis study assesses VECSC effectiveness based on predicted outcomes. Method: A simple susceptible-infected-recovery model was applied to data of patients with symptoms in Japan during January 14 through March 25. The respective reproduction numbers were estimated before VECSC (R), during VECSC (Re), and after VECSC (Ra).\n\nResultsResults suggest R before VECSC as 1.987 [1.908, 2.055], Re during VECSC as 1.122 [0.980, 1.260], and Ra after VECSC as 3.086 [2.529, 3.739].\n\nDiscussion and ConclusionResults demonstrated that VECSC can reduce COVID-19 infectiousness considerably, but the value of R rose to exceed 2.5 after VECSC.","published":"10.1371\/journal.pone.0239455","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20038679","title":"Screening and managing of suspected or confirmed novel coronavirus (COVID-19) patients: experiences from a tertiary hospital outside Hubei province","authors":"Pu, H.; Xu, Y.; Doig, G. S.; Zhou, Y.","author_corresponding":"Yan Zhou","author_corresponding_institution":"West China Hospital of Sichuan University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038679.source.xml","abstract":"ObjectivesTo report our experiences screening and managing patients with suspected or confirmed novel coronavirus (COVID-19) disease using a hospital-specific protocol.\n\nDesignLongitudinal cohort study.\n\nSettingA 1,200 bed tertiary care teaching hospital in Chengdu, Sichuan, China.\n\nParticipants802 adults presenting to hospital with concerns of having COVID-19, 1,246 inpatients and 2,531 hospital visitors.\n\nInterventionsScreening and management of patients using a hospital-specific protocol, which included fever triage, monitoring visitors and patients, emergency response, personnel training for healthcare team members, health education for patients and family, medical materials management, disinfection and wastes disposal protocols.\n\nResultsBetween 23 January and 28 February 2020, 73 people were identified as having fever plus respiratory signs with\/without a history of exposure and were tested for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by our hospital lab using RT PCR. Forty-five of these 73 people were subsequently excluded based on one negative RT PCR result plus positive results to quick screening tests for flu or other respiratory viruses. The remaining 28 people received a second RT PCR test 24 h later. Three people were confirmed positive for COVID-19 based on two consecutive positive RT PCR tests whilst 25 people were excluded based on two consecutive negative tests. The three COVID-19 confirmed cases received non-critical care. There were no new infections of medical staff or new infections of other hospital inpatients.\n\nConclusionsA hospital-specific protocol for screening and management is necessary for reliably identifying suspected or confirmed COVID-19 patients during an outbreak. All three cases were detected as a result of vigilant monitoring of hospital visitors. Whilst screening out-patients presenting to a fever clinic remains important, monitoring visitors must not be overlooked.\n\nStrengths and limitations of this study{blacktriangleright} We report a hospital-specific protocol used to screen and manage people presenting to our hospital fever clinic, inpatients and visitors during an outbreak of novel coronavirus (COVID-19) pneumonia in Chengdu, Sichuan province.\n{blacktriangleright}Key components of the protocol included: a three-level fever triage process; monitoring visitors and inpatients, formation of an emergency response team for COVID-19, personnel training for healthcare team members, health education for patients and family, medical materials management, and disinfection and wastes disposal protocols.\n{blacktriangleright}The ability to test nucleic acid of SARS-CoV-2 using RT PCR in the hospital greatly shortened the time from the detection of patients to diagnosis, and was beneficial to the control of the transmission of the SARS-CoV-2.\n{blacktriangleright}Although our process detected few patients, comparison with other processes, when they are published, will allow the identification of the optimal approach for screening and management.\n{blacktriangleright}We suggest that if all resources had been focused on screening people through our fever clinic, we would have missed important in-hospital risks of transmitting COVID-19: The detection of a hospital visitor with COVID-19 led to the detection of an inpatient with COVID-19.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040063","title":"Clinically Applicable Deep Learning for Intracranial Aneurysm Detection in Computed Tomography Angiography Images: A Comprehensive Multicohort Study","authors":"SHI, Z.; Miao, C. C.; Pan, C. W.; Chai, X.; Li, X. L.; Xia, S.; Gu, Y.; Zhang, Y. G.; Hu, B.; Xu, W. D.; Zhou, C. S.; Luo, S.; Wang, H.; Mao, L.; Liang, K. M.; Yu, Y. Z.; Lu, G. M.; Zhang, L. J.","author_corresponding":"Long Jiang Zhang","author_corresponding_institution":"Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"radiology and imaging","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20040063.source.xml","abstract":"Intracranial aneurysm is a common life-threatening disease. CTA is recommended as a standard diagnosis tool, while the interpretation is time-consuming and challenging. We presented a novel deep-learning-based framework trained on 1,177 DSA verified bone-removal CTA cases. The framework had excellent tolerance to the influence of occult cases of CTA-negative but DSA-positive aneurysms, image quality, and manufacturers. Simulated real-world studies were conducted in consecutive internal and external cohorts, achieving improved sensitivity and negative predictive value than radiologists. A specific cohort of suspected acute ischemic stroke was employed and found 96.8% predicted-negative cases can be trusted with high confidence, leading to reducing in human burden. A prospective study is warranted to determine whether the algorithm could improve patients care in comparison to radiologists assessment.","published":"10.1038\/s41467-020-19527-w","server":"medrxiv"},{"doi":"10.1101\/2020.03.18.20037374","title":"Operationalisation of the learned non-use phenomenon - A Delphi study.","authors":"Hirsch, T.; Barthel, M.; Aarts, P.; Chen, Y.-A.; Freivogel, S.; Johnson, M. J.; Jones, T. A.; Jongsma, M. L. A.; Maier, M.; Punt, D.; Sterr, A.; Wolf, S. L.; Heise, K.-F.","author_corresponding":"Kirstin-Friederike Heise","author_corresponding_institution":"Research Center for Movement Control and Neuroplasticity, Department of Movement Sciences, KU Leuven, Leuven, Belgium","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"rehabilitation medicine and physical therapy","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20037374.source.xml","abstract":"The discrepancy between residual functional capacity and reduced use of the contralesional hand, frequently observed after a brain lesion, has been termed Learned Non-Use (LNU) and is thought to depend on the interaction of neuronal mechanisms during recovery and learning-dependent mechanisms such as negative reinforcement. Despite the generally accepted existence of the LNU phenomenon among clinicians and researchers, no unequivocal and transdisciplinary definition exists to date. Furthermore, although therapeutic approaches are implemented in clinical practice to explicitly target LNU, no standardized diagnostic routine is described in the current literature.\n\nBased on a structured group communication following the Delphi method among clinical and scientific experts in the field of LNU, knowledge from both, the work with patient populations and with animal models, was synthesized and integrated to reach consensus regarding a transdisciplinary definition of the LNU phenomenon. Furthermore, the mode and strategy of the diagnostic process, as well as the sources of information and outcome parameters relevant for the clinical decision making, were described with a wide range showing the current lack of a consistent universal diagnostic approach. Building on these results, the need for the development of a structured diagnostic procedure and its implementation into clinical practice is emphasized. Moreover, it exists a striking gap between the prevailing hypotheses regarding the mechanisms underlying the LNU phenomenon and the actual evidence. Therefore, basic research is needed to bridge between bedside and bench and eventually improve clinical decision making and further development of interventional strategies beyond the field of stroke rehabilitation.","published":"10.1177\/1545968321999064","server":"medrxiv"},{"doi":"10.1101\/2020.03.16.20037002","title":"Improving estimation of Parkinson's disease risk - The enhanced PREDICT-PD algorithm","authors":"Bestwick, J. P.; Auger, S.; Simonet, C.; Rees, R. N.; Rack, D.; Jitlal, M.; Giovannoni, G.; Lees, A.; Cuzick, J.; Schrag, A.; Noyce, A. J.","author_corresponding":"Alastair J Noyce","author_corresponding_institution":"Queen Mary University of London","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.16.20037002.source.xml","abstract":"BackgroundWe previously reported a basic algorithm to identify risk of Parkinsons disease (PD) using published data on risk factors and prodromal features. Using this algorithm, the PREDICT-PD study identified individuals at increased risk of PD, using tapping speed, hyposmia and REM sleep behaviour disorder (RBD) as \"intermediate\" markers of prodromal PD until sufficient incident cases accrued.\n\nObjectivesTo develop and test an enhanced algorithm which incorporates these intermediate markers into the risk model.\n\nMethodsIntermediate markers were incorporated into risk estimates, and likelihood ratios for both the presence and absence of risk factors were used. Risk estimates were compared using the enhanced and the basic algorithm in members of the PREDICT-PD pilot cohort.\n\nResultsThe enhanced PREDICT-PD algorithm yielded a much greater range of risk estimates than the basic algorithm (346 - 784-fold difference between the 10th and 90th centiles vs 10 12-fold respectively). There was a greater increase in risk of PD with increasing risk scores for the enhanced algorithm than for the basic algorithm (hazard ratios per one standard deviation increase in log risk of 2.73 [95% CI 1.68 - 4.45; p<0.001] versus 1.47 [95% CI 0.86 2.51; p=0.16] respectively). Estimates from the enhanced algorithm also correlated more closely with subclinical striatal DaT-SPECT dopamine depletion (R2=0.14, p=0.010 vs R2=0.043, p=0.17).\n\nConclusionsIncorporating the previous intermediate markers of prodromal PD and using likelihood ratios improved the accuracy of the PREDICT-PD prediction algorithm for PD.","published":"10.1038\/s41531-021-00176-9","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20021113","title":"Relevance of brain MRI in patients with uveitis: retrospective cohort on 402 patients","authors":"Chirpaz, N.; Kerever, S.; Gavoille, A.; Kodjikian, L.; Denis, P.; Mathis, T.; Jamilloux, Y.; Seve, P.","author_corresponding":"Pascal Seve","author_corresponding_institution":"Hospital Croix-Rousse, Internal Medicine Lyon, Rhone-Alpes , FR","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"ophthalmology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.22.20021113.source.xml","abstract":"AimTo assess the diagnostic value of brain magnetic resonance imaging (bMRI) for the etiological diagnosis of uveitis and to establish predictive factors associated with its advantageous use.\n\nMethodsRetrospective study on all patients with de novo uveitis who were referred to our tertiary hospital and who underwent a bMRI between 2003 and 2018. The bMRI was considered useful if it served to confirm a diagnosis or correct a misdiagnosis. We also collected characteristics of uveitis and associated ophthalmological and neurological clinical signs.\n\nResultsBrain MRI was contributive in 19 out of 402 cases (5%): 10 multiple sclerosis, 5 radiologically isolated syndromes, and 4 oculocerebral lymphomas.\n\nA total of 34 (8%) had neurological signs and 13 (38%) of those patients had a contributive bMRI. Meanwhile, in the absence of neurological signs, 1% of bMRIs were contributive, and none of them resulted in specific treatment.\n\nAmong patients with a contributive bMRI, 68% had neurological signs. Univariate analysis established that neurological signs (p<0.001), granulomatous uveitis (p=0.003), retinal vasculitis (p=0.002), and intermediate uveitis (p<0.001) were all significantly associated with a contributive bMRI. Multivariate analysis confirms the significant association of neurological signs (p<0.001) and intermediate uveitis (p=0.01).\n\nPatients with oculocerebral lymphoma were significantly older (p<0.001) and all were above 40 years of age.\n\nConclusionBrain MRI appears to be a relevant and contributive exam, but it should be performed in cases of intermediate\/posterior uveitis or panuveitis accompanied by neurological signs, retinal vasculitis, or in patients older than 40, to rule out an oculocerebral lymphoma.","published":"10.1080\/09273948.2020.1870145","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040568","title":"Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation","authors":"Hill, E. M.; Petrou, S.; Forster, H.; de Lusignan, S.; Yonova, I.; Keeling, M. J.","author_corresponding":"Edward M Hill","author_corresponding_institution":"University of Warwick","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health economics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20040568.source.xml","abstract":"For infectious disease prevention, policy-makers are typically required to base policy decisions in light of operational and monetary restrictions, prohibiting implementation of all candidate interventions. To inform the evidence-base underpinning policy decision making, mathematical and health economic modelling can be a valuable constituent. Applied to England, this study aims to identify the optimal target age groups when extending a seasonal influenza vaccination programme of at-risk individuals to those individuals at low risk of developing complications following infection. To perform this analysis, we utilise an age- and strain-structured transmission model that includes immunity propagation mechanisms which link prior season epidemiological outcomes to immunity at the beginning of the following season. Making use of surveillance data from the past decade in conjunction with our dynamic model, we simulate transmission dynamics of seasonal influenza in England from 2012 to 2018. We infer that modified susceptibility due to natural infection in the previous influenza season is the only immunity propagation mechanism to deliver a non-negligible impact on the transmission dynamics. Further, we discerned case ascertainment to be higher for young infants compared to adults under 65 years old, and uncovered a decrease in case ascertainment as age increased from 65 to 85 years of age. Our health economic appraisal sweeps vaccination age space to determine threshold vaccine dose prices achieving cost-effectiveness under differing paired strategies. In particular, we model offering vaccination to all those low-risk individuals younger than a given age (but no younger than two years old) and all low-risk individuals older than a given age, while maintaining vaccination of at-risk individuals of any age. All posited strategies were deemed cost-effective. In general, the addition of low-risk vaccination programmes whose coverage encompassed children and young adults (aged 20 and below) were highly cost-effective. The inclusion of old age-groups to the low-risk programme typically lessened the cost-effectiveness. Notably, elderly-centric programmes vaccinating from 65-75 years and above had the least permitted expense per vaccine.","published":"10.1371\/journal.pcbi.1008278","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20037325","title":"Predicting COVID-19 malignant progression with AI techniques","authors":"Bai, X.; Fang, C.; Zhou, Y.; Bai, S.; Liu, Z.; Chen, Q.; Xu, Y.; Xia, T.; Gong, S.; Xie, X.; Song, D.; Du, R.; Zhou, C.; Chen, C.; Nie, D.; Tu, D.; Zhang, C.; Liu, X.; Qin, L.; Chen, W.","author_corresponding":"Weiwei Chen","author_corresponding_institution":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20037325.source.xml","abstract":"Background and purposeThe worldwide pandemic of coronavirus disease 2019 (COVID-19) greatly challenges public medical systems. With limited medical resources, the treatment priority is determined by the severity of patients. However, many mild outpatients quickly deteriorate into severe\/critical stage. It is crucial to early identify them and give timely treatment for optimizing treatment strategy and reducing mortality. This study aims to establish an AI model to predict mild patients with potential malignant progression.\n\nMethodsA total of 133 consecutively mild COVID-19 patients at admission who was hospitalized in Wuhan Pulmonary Hospital from January 3 to February 13, 2020, were selected in this retrospective IRB-approved study. All mild patients were categorized into groups with or without malignant progression. The clinical and laboratory data at admission, the first CT, and the follow-up CT at the severe\/critical stage of the two groups were compared. Both multivariate logistic regression and deep learning-based methods were used to build the prediction models, with their area under ROC curves (AUC) compared.\n\nResultsMultivariate logistic regression depicted 6 risk factors for malignant progression: age >55years (OR 5.334, 95%CI 1.8-15.803), comorbid with hypertension (OR 5.093, 95%CI 1.236-20.986), a decrease of albumin (OR 4.01, 95%CI 1.216-13.223), a decrease of lymphocyte (OR 3.459, 95%CI 1.067-11.209), the progressive consolidation from CT1 to CTsevere (OR 1.235, 95%CI 1.018-1.498), and elevated HCRP (OR 1.015, 95%CI 1.002-1.029); and one protective factor: the presence of fibrosis at CT1 (OR 0.656, 95%CI 0.473-0.91). By combining the clinical data and the temporal information of the CT data, our deep learning-based models achieved the best AUC of 0.954, which outperformed logistic regression (AUC: 0.893),\n\nConclusionsOur deep learning-based methods can identify the mild patients who are easy to deteriorate into severe\/critical cases efficiently and accurately, which undoubtedly helps to optimize the treatment strategy, reduce mortality, and relieve the medical pressure.","published":"10.1016\/j.media.2021.102096","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20034447","title":"Potential biochemical markers to identify severe cases among COVID-19 patients","authors":"XIANG, J.; WEN, J.; YUAN, X.; Xiong, S.; ZHOU, X.; LIU, C.; MIN, X.","author_corresponding":"XUN MIN","author_corresponding_institution":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China.","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20034447.source.xml","abstract":"There is a high mortality and long hospitalization period for severe cases with 2019 novel coronavirus disease (COVID-19) pneumonia. Therefore, it makes sense to search for a potential biomarker that could rapidly and effectively identify severe cases early. Clinical samples from 28 cases of COVID-19 (8 severe cases, 20 mild cases) in Zunyi District from January 29, 2020 to February 21, 2020 were collected and otherwise statistically analysed for biochemical markers. Serum urea, creatinine (CREA) and cystatin C (CysC) concentrations in severe COVID-19 patients were significantly higher than those in mild COVID-19 patients (P<0.001), and there were also significant differences in serum direct bilirubin (DBIL), cholinesterase (CHE) and lactate dehydrogenase (LDH) concentrations between severe and mild COVID-19 patients (P<0.05). Serum urea, CREA, CysC, DBIL, CHE and LDH could be used to distinguish severe COVID-19 cases from mild COVID-19 cases. In particular, serum biomarkers, including urea, CREA, CysC, which reflect glomerular filtration function, may have some significance as potential indicators for the early diagnosis of severe COVID-19 and to distinguish it from mild COVID-19. Glomerular filtration function injury in severe COVID-19 patients should also be considered by clinicians.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20038919","title":"The impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak - evidence from China","authors":"Shi, P.; Dong, Y.; Yan, H.; Li, X.; Zhao, C.; Liu, W.; He, M.; Tang, S.; Xi, S.","author_corresponding":"Shuhua Xi","author_corresponding_institution":"Department of Environmental Health, School of Public Health, China Medical University, Shenyang, China","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"occupational and environmental health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20038919.source.xml","abstract":"OBJECTIVETo investigate the impact of temperature and absolute humidity on the coronavirus disease 2019 (COVID-19) outbreak.\n\nDESIGNEcological study.\n\nSETTING31 provincial-level regions in mainland China.\n\nMAIN OUTCOME MEASURESData on COVID-19 incidence and climate between Jan 20 and Feb 29, 2020.\n\nRESULTSThe number of new confirm COVID-19 cases in mainland China peaked on Feb 1, 2020. COVID-19 daily incidence were lowest at -10 {degrees}C and highest at 10 {degrees}C, while the maximum incidence was observed at the absolute humidity of approximately 7 g\/m3. COVID-19 incidence changed with temperature as daily incidence decreased when the temperature rose. No significant association between COVID-19 incidence and absolute humidity was observed in distributed lag nonlinear models. Additionally, A modified susceptible-exposed-infectious-recovered (M-SEIR) model confirmed that transmission rate decreased with the increase of temperature, leading to further decrease of infection rate and outbreak scale.\n\nCONCLUSIONTemperature is an environmental driver of the COVID-19 outbreak in China. Lower and higher temperatures might be positive to decrease the COVID-19 incidence. M-SEIR models help to better evaluate environmental and social impacts on COVID-19.\n\nWhat is already known on this topicO_LIMany infectious diseases present an environmental pattern in their incidence.\nC_LIO_LIEnvironmental factors, such as climate and weather condition, could drive the space and time correlations of infectious diseases, including influenza.\nC_LIO_LISevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be transmitted through aerosols, large droplets, or direct contact with secretions (or fomites) as influenza virus can.\nC_LIO_LILittle is known about environmental pattern in COVID-19 incidence.\nC_LI\n\nWhat this study addsO_LIThe significant association between COVID-19 daily incidence and temperature was confirmed, using 3 methods, based on the data on COVID-19 and weather from 31 provincial-level regions in mainland China.\nC_LIO_LIEnvironmental factors were considered on the basis of SEIR model, and a modified susceptible-exposed-infectious-recovered (M-SEIR) model was developed.\nC_LIO_LISimulations of the COVID-19 outbreak in Wuhan presented similar effects of temperature on incidence as the incidence decrease with the increase of temperature.\nC_LI","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20040774","title":"Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients","authors":"Chen, X.; Hu, W.; Ling, J.; Mo, P.; Zhang, Y.; Jiang, Q.; Ma, Z.; Cao, Q.; Deng, L.; Song, S.; Zheng, R.; Gao, S.; Ke, H.; Gui, X.; Lundkvist, A.; Li, J.; Lindahl, J. F.; Xiong, Y.","author_corresponding":"Yong Xiong","author_corresponding_institution":"Zhongnan Hospital of Wuhan University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20040774.source.xml","abstract":"ObjectivesComorbidities have significant indications for the disease outcome of COVID-19, however which underlying diseases that contribute the most to aggravate the conditions of COVID-19 patients is still largely unknown. SARS-CoV-2 viral clearance is a golden standard for defining the recovery of COVID-19 infections. To dissect the underlying diseases that could impact on viral clearance, we enrolled 106 COVID-19 patients who were hospitalized in the Zhongnan Hospital of Wuhan University, Wuhan, China between Jan 5 and Feb 25, 2020.\n\nMethodologyWe comprehensively analyzed demographic, clinical and laboratory data, as well as patient treatment records. Survival analyses with Kaplan-Meier and Cox regression modelling were employed to identify factors influencing the viral clearance negatively.\n\nResultsWe found that increasing age, male gender, and angiotensin-converting enzyme 2 (ACE2) associated factors (including hypertension, diabetes, and cardiovascular diseases) adversely affected the viral clearance. Furthermore, analysis by a random forest survival model pointed out hypertension, cortisone treatment, gender, and age as the four most important variables.\n\nConclusionsWe conclude that patients at old age, males, and\/or having diseases associated with high expression of ACE2 will have worse prognosis during a COVID-19 infections.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20040782","title":"A comparative multi-centre study on the clinical and imaging features of comfirmed and uncomfirmed patients with COVID-19","authors":"Miao, C.; Zhuang, J.; Jin, M.; Xiong, H.; Huang, P.; Zhao, Q.; Miao, L.; Du, J.; Yang, X.; Huang, P.; Hong, J.","author_corresponding":"Jiang Hong","author_corresponding_institution":"Shanghai General Hospital, Shanghai Jiao Tong University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20040782.source.xml","abstract":"BackgroundPrevious studies had described the differences in clinical characteristics between ICU and non-ICU patients. However, seldom study focused on confirmed and unconfirmed groups. Our aim was to compare clinical and imaging characteristics of COVID-19 patients outside Hubei province between confirmed and unconfirmed group.\n\nMethodsWe retrospectively enrolled 163 consecutive adult patients with suspected COVID-19 from three tertiary hospitals in two provinces outside Hubei province from January 12, 2020 to February 13, 2020 and the differences in epidemiological, clinical, laboratory and imaging characteristics between the two groups were compared.\n\nResultsThis study enrolled 163 patients with 62 confirmed cases and 101 unconfirmed cases. Most confirmed patients were clustered (31, 50.0%) and with definite epidemiological exposure. Symptoms of COVID-19 were nonspecific, largely fever and dry cough. Laboratory findings in confirmed group were characterized by normal or reduced white blood cell count, reduced the absolute value of lymphocytes, and elevated levels of C-reactive protein (CRP) and accelerated Erythrocyte sedimentation rate (ESR). The typical chest CT imaging features of patients with confirmed COVID-19 were peripherally distributed multifocal GGO with predominance in the lower lung lobe. Compared with unconfirmed patients, confirmed patients had significantly higher proportion of dry cough, leucopenia, lymphopenia and accelerated ESR (P<0.05); but not with alanine aminotransferase, aspartate aminotransferase, D-dimer, lactic dehydrogenase, and myoglobin (P>0.05). Proportion of peripheral, bilateral or lower lung distribution and multi-lobe involvement, GGO, crazy-paving pattern, air bronchogram and pleural thickening in the confirmed group were also higher (P<0.05).\n\nConclusionsSymptoms of COVID-19 were nonspecific. Leukopenia, lymphopenia and ESR, as well as chest CT could be used as a clue for clinical diagnosis of COVID-19.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040154","title":"Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany","authors":"magal, p.; Webb, G.","author_corresponding":"pierre magal","author_corresponding_institution":"University of Bordeaux","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20040154.source.xml","abstract":"We model the COVID-19 coronavirus epidemic in South Korea, Italy, France, and Germany. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.20.20040048","title":"Window of Opportunity for Mitigation to Prevent Overflow of ICU capacity in Chicago by COVID-19","authors":"Maslov, S.; Goldenfeld, N.","author_corresponding":"Sergei Maslov","author_corresponding_institution":"University of Illinois at Urbana-Champaign","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.20.20040048.source.xml","abstract":"Executive SummaryWe estimate the growth in demand for ICU beds in Chicago during the emerging COVID-19 epidemic, using state-of-the-art computer simulations calibrated for the SARS-CoV-2 virus. The questions we address are these:\n\nO_LIWill the ICU capacity in Chicago be exceeded, and if so by how much?\nC_LIO_LICan strong mitigation strategies, such as lockdown or shelter in place order, prevent the overflow of capacity?\nC_LIO_LIWhen should such strategies be implemented?\nC_LI\n\nOur answers are as follows:\n\nO_LIThe ICU capacity may be exceeded by a large amount, probably by a factor of ten.\nC_LIO_LIStrong mitigation can avert this emergency situation potentially, but even that will not work if implemented too late.\nC_LIO_LIIf the strong mitigation precedes April 1st, then the growth of COVID-19 can be controlled and the ICU capacity could be adequate. The earlier the strong mitigation is implemented, the greater the probability that it will be successful. After around April 1 2020, any strong mitigation will not avert the emergency situation. In Italy, the lockdown occurred too late and the number of deaths is still doubling every 2.3 days. It is difficult to be sure about the precise dates for this window of opportunity, due to the inherent uncertainties in computer simulation. But there is high confidence in the main conclusion that it exists and will soon be closed.\nC_LI\n\nOur conclusion is that, being fully cognizant of the societal trade-offs, there is a rapidly closing window of opportunity to avert a worst-case scenario in Chicago, but only with strong mitigation\/lockdown implemented in the next week at the latest. If this window is missed, the epidemic will get worse and then strong mitigation\/lockdown will be required after all, but it will be too late.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20041079","title":"Social distancing strategies for curbing the COVID-19 epidemic","authors":"Kissler, S. M.; Tedijanto, C.; Lipsitch, M.; Grad, Y.","author_corresponding":"Yonatan Grad","author_corresponding_institution":"Harvard T.H. Chan School of Public Health","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20041079.source.xml","abstract":"The SARS-CoV-2 pandemic is straining healthcare resources worldwide, prompting social distancing measures to reduce transmission intensity. The amount of social distancing needed to curb the SARS-CoV-2 epidemic in the context of seasonally varying transmission remains unclear. Using a mathematical model, we assessed that one-time interventions will be insufficient to maintain COVID-19 prevalence within the critical care capacity of the United States. Seasonal variation in transmission will facilitate epidemic control during the summer months but could lead to an intense resurgence in the autumn. Intermittent distancing measures can maintain control of the epidemic, but without other interventions, these measures may be necessary into 2022. Increasing critical care capacity could reduce the duration of the SARS-CoV-2 epidemic while ensuring that critically ill patients receive appropriate care.\n\nSummaryOne-time distancing results in a fall COVID-19 peak. Intermittent efforts require greater hospital capacity and surveillance.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20040915","title":"Mechanistic-statistical SIR modelling for early estimation of the actual number of cases and mortality rate from COVID-19","authors":"Roques, L.; Klein, E.; Papaix, J.; Soubeyrand, S.","author_corresponding":"Lionel Roques","author_corresponding_institution":"INRAE","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20040915.source.xml","abstract":"The number of screening tests carried out in France and the methodology used to target the patients tested do not allow for a direct computation of the actual number of cases and the infection fatality ratio (IFR). The main objective of this work is to estimate the actual number of people infected with COVID-19 and to deduce the IFR during the observation window in France. We develop a  mechanistic-statistical approach coupling a SIR epidemiological model describing the unobserved epidemiological dynamics, a probabilistic model describing the data acquisition process and a statistical inference method. The actual number of infected cases in France is probably higher than the observations: we find here a factor x8 (95%-CI: 5-12) which leads to an IFR in France of 0.5% (95%-CI: 0.3 - 0.8) based on hospital death counting data. Adjusting for the number of deaths in nursing homes, we obtain an IFR of 0.8% (95%-CI: 0.45 - 1.25). This IFR is consistent with previous findings in China (0.66%) and in the UK (0.9%) and lower than the value previously computed on the Diamond Princess cruise ship data (1.3%).","published":"10.3390\/biology9050097","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038786","title":"Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.","authors":"Hollis, R.; Thomson, J. P.; Stanley, B.; Churchman, M.; Meynert, A.; Rye, T.; Bartos, C.; Iida, Y.; Croy, I.; Mackean, M.; Nussey, F.; Okamoto, A.; Semple, C. A. M.; Gourley, C.; Herrington, C. S.","author_corresponding":"C Simon Herrington","author_corresponding_institution":"University of Edinburgh","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.19.20038786.source.xml","abstract":"Endometrioid ovarian carcinoma (EnOC) is an under-investigated type of ovarian carcinoma. Here, we report the largest genomic study of EnOCs to date, performing whole exome sequencing of 112 cases following rigorous pathological assessment. High frequencies of mutation were detected in CTNNB1(43%), PIK3CA(43%), ARID1A(36%), PTEN(29%), TP53(26%) and SOX8(19%), a novel target of recurrent mutation in EnOC. POLE and mismatch repair protein-encoding genes were mutated at lower frequency (6%, 18%) with significant co-occurrence. A molecular taxonomy was constructed using a novel algorithm (PRISTINE), identifying clinically distinct EnOC subtypes: TP53m cases demonstrated greater genomic complexity, were frequently FIGO stage III\/IV at diagnosis (48%) and incompletely debulked (44%), and demonstrated inferior survival; conversely, CTNNB1m cases demonstrated low complexity and excellent clinical outcome, were predominantly stage I\/II at diagnosis (89%) and completely resected (87%). Tumour complexity provides further resolution within the TP53wt\/CTNNB1wt group. Moreover, we identify the WNT, MAPK\/RAS and PI3K pathways as good candidate targets for molecular therapeutics in EnOC.","published":"10.1038\/s41467-020-18819-5","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040329","title":"Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries","authors":"Ma, S.; Zhang, J.; Zeng, M.; Yun, Q.; Guo, W.; Zheng, Y.; Zhao, S.; Wang, M. H.; Yang, Z.","author_corresponding":"Zuyao Yang","author_corresponding_institution":"JC School of Public Health and Primary Care, the Chinese University of Hong Kong","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20040329.source.xml","abstract":"BackgroundThe outbreak of coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization, while several key epidemiological parameters of the disease remain to be clarified. This study aimed to obtain robust estimates of the incubation period, upper limit of latent period (interval between infectors exposure and infectees exposure), serial interval, time point of exposure (the day of infectees exposure to infector relative to the latters symptom onset date) and basic reproduction number (R0) of COVID-19.\n\nMethodsBetween late February and early March of 2020, the individual data of laboratory confirmed cases of COVID-19 were retrieved from 10728 publicly available reports released by the health authorities of and outside China and from 1790 publications identified in PubMed and CNKI. To be eligible, a report had to contain the data that allowed for estimation of at least one parameter. As relevant data mainly came from clustering cases, the clusters for which no evidence was available to establish transmission order were all excluded to ensure accuracy of estimates. Additionally, only the cases with an exposure period spanning 3 days or less were included in the estimation of parameters involving exposure date, and a simple method for determining exposure date was adopted to ensure the error of estimates be small (< 0.3 day). Depending on specific parameters, three or four of normal, lognormal, Weibull, and gamma distributions were fitted to the datasets and the results from appropriate models were presented.\n\nFindingsIn total, 1155 cases from China, Japan, Singapore, South Korea, Vietnam, Germany and Malaysia were included for the final analysis. The mean and standard deviation were 7.44 days and 4.39 days for incubation period, 2.52 days and 3.95 days for the upper limit of latent period, 6.70 days and 5.20 days for serial interval, and -0.19 day (i.e., 0.19 day before infectors symptom onset) and 3.32 days for time point of exposure. R0 was estimated to be 1.70 and 1.78 based on two different formulas. For 39 (6.64%) cases, the incubation periods were longer than 14 days. In 102 (43.78%) infector-infectee pairs, transmission occurred before infectors symptom onsets. In 27 (3.92%) infector-infectee pairs, infectees symptom onsets occurred before those of infectors. Stratified analysis showed that incubation period and serial interval were consistently longer for those with less severe disease and for those whose primary cases had less severe disease. Asymptomatic transmission was also observed.\n\nInterpretationThis study obtained robust estimates of several key epidemiological parameters of COVID-19. The findings support current practice of 14-day quarantine of persons with potential exposure, but also suggest that longer monitoring periods might be needed for selected groups. The estimates of serial interval, time point of exposure and latent period provide consistent evidence on pre-symptomatic transmission. This together with asymptomatic transmission and the generally longer incubation and serial interval of less severe cases suggests a high risk of long-term epidemic in the absence of appropriate control measures.\n\nFundingThis work received no funding from any source.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040121","title":"Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study","authors":"Zhang, F.; Yang, D.; Li, J.; Gao, P.; Chen, T.; Cheng, Z.; Cheng, K.; Fang, Q.; Pan, W.; Yi, C.; Fan, H.; Wu, Y.; Li, L.; Fang, Y.; Liu, J.; Tian, G.; He, L.","author_corresponding":"Liqun He","author_corresponding_institution":"Department of Cardiology, Wuhan No.1 Hospital","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20040121.source.xml","abstract":"BackgroundSince December 2019, a cluster of coronavirus disease 2019 (COVID-19) occurred in Wuhan, Hubei Province, China and spread rapidly from China to other countries. In-hospital mortality are high in severe cases and cardiac injury characterized by elevated cardiac troponin are common among them. The mechanism of cardiac injury and the relationship between cardiac injury and in-hospital mortality remained unclear. Studies focused on cardiac injury in COVID-19 patients are scarce.\n\nObjectivesTo investigate the association between cardiac injury and in-hospital mortality of patients with confirmed or suspected COVID-19.\n\nMethodsDemographic, clinical, treatment, and laboratory data of consecutive confirmed or suspected COVID-19 patients admitted in Wuhan No.1 Hospital from 25th December, 2019 to 15th February, 2020 were extracted from electronic medical records and were retrospectively reviewed and analyzed. Univariate and multivariate Cox regression analysis were used to explore the risk factors associated with in-hospital death.\n\nResultsA total of 110 patients with confirmed (n=80) or suspected (n=30) COVID-19 were screened and 48 patients (female 31.3%, mean age 70.58{+\/-}13.38 year old) among them with high-sensitivity cardiac troponin I (hs-cTnI) test within 48 hours after admission were included, of whom 17 (17\/48, 35.4%) died in hospital while 31 (31\/48, 64.6%) were discharged or transferred to other hospital. High-sensitivity cardiac troponin I was elevated in 13 (13\/48, 27.1%) patents. Multivariate Cox regression analysis showed pulse oximetry of oxygen saturation (SpO2) on admission (HR 0.704, 95% CI 0.546-0.909, per 1% decrease, p=0.007), elevated hs-cTnI (HR 10.902, 95% 1.279-92.927, p=0.029) and elevated d-dimer (HR 1.103, 95%CI 1.034-1.176, per 1mg\/L increase, p=0.003) on admission were independently associated with in-hospital mortality.\n\nConclusionsCardiac injury defined by hs-cTnI elevation and elevated d-dimer on admission were risk factors for in-hospital death, while higher SpO2 could be seen as a protective factor, which could help clinicians to identify patients with adverse outcome at the early stage of COVID-19.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20039867","title":"A New, Simple Projection Model for COVID-19 Pandemic","authors":"Lu, J.","author_corresponding":"Jian Lu","author_corresponding_institution":"City University of Hong Kong","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20039867.source.xml","abstract":"BackgroundWith the worldwide outbreak of COVID-19, an accurate model to predict how the coronavirus pandemic will evolve in individual countries becomes important and urgent. Our goal is to provide a prediction model to help policy makers in different countries address the epidemic outbreak and adjust the control policies to contain the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) more effectively.\n\nMethodsUnlike the classic public health and virus propagation models, this new projection model takes both government intervention and public response into account to generate reliable projections of the outbreak 10 days to 2 weeks in advance. This method is an observation based projection similar than the classic Moores Law in miroelectronics. The Moores law is not based on any physics law and yet has anticipated the development of microelectronics for decades. This work is an empirical relation to decribe the evolution of epidemic to pandemic situations in different countries. The country was selected as an observation unit because the regulation and political decision is an national decision for numerous measures such as the implementation of social distancing, the quarantine of suspected cases, and the closing of borders to achieve territorial containment.\n\nFindingsThis model has been successfully applied to predict the evolution of pendemic situation in China. Then the model was also validated by the South Korean data. With a reduction of cases calculated as reduction coefficient of the increase rate of daily cases Rc = 2% per day, we observed a very efficient policy with a strict systematic control in both China and South Korea. For the moment, the Canada, USA, Australia may have difficulties to limit the fast evolution of the epidemic. With a Rc<0.5%, its particularly important for the USA to consider escalating the control measures because the affected cases can reach more than one million very soon.\n\nInterpertationDue to the difference of national disciplines and historical culture, the national policy may be implemented and observed with different efficiency. The starting point where the government decided to apply total containment can also play a key role for the evolution of the pendemic situation. The model will allow each national government of the nations still affected by the pandemic to project the situation for the coming 10 to 14 days. Its very important for the deployment of national and international efforts to stop the pandemic situation.\n\nFundingNational Key R&D Program of China (Ministry of Science & Technology (MOST, China))","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040139","title":"Tracking and forecasting milepost moments of the epidemic in the early-outbreak: framework and applications to the COVID-19","authors":"Wang, H.; Zhang, Y.; Lu, S.; Wang, S.","author_corresponding":"Shanshan Wang","author_corresponding_institution":"School of Economics and Management, Beihang University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20040139.source.xml","abstract":"BackgroundThe outbreak of the 2019 novel coronavirus (COVID-19) has attracted global attention. In the early stage of the outbreak, the most important question concerns some meaningful milepost moments, including (1) the time when the number of daily confirmed cases decreases, (2) the time when the number of daily confirmed cases becomes smaller than that of the daily removed (recovered and death), (3) the time when the number of daily confirmed cases becomes zero, and (4) the time when the number of patients treated in hospital is zero, which indicates the end of the epidemic. Intuitively, the former two can be regarded as two important turning points which indicate the alleviation of epidemic to some extent, while the latter two as two \"zero\" points, respectively. Unfortunately, it is extremely difficult to make right and precise prediction due to the limited amount of available data at a early stage of the outbreak.\n\nMethodTo address it, in this paper, we propose a flexible framework incorporating the effectiveness of the government control to forecast the whole process of a new unknown infectious disease in its early-outbreak. Specially, we first establish the iconic indicators to characterize the extent of epidemic spread, yielding four periods of the whole process corresponding to the four meaningful milepost moments: two turning points and two \"zero\" points. Then we develop the tracking and forecasting procedure with mild and reasonable assumption. Finally we apply it to analyze and evaluate the COVID-19 using the public available data for mainland China beyond Hubei Province from the China Centers for Disease Control (CDC) during the period of Jan 29th, 2020, to Feb 29th, 2020, which shows the effectiveness of the proposed procedure.\n\nResultsResults show that our model can clearly outline the development of the epidemic at a very early stage. The first prediction results on Jan 29th reveal that the first and second milepost moments for mainland China beyond Hubei Province would appear on Jan 31st and Feb 14th respectively, which are only one day and three days behind the real world situations. Forecasting results indicate that the number of newly confirmed cases will become zero in the mid-late March, and the number of patients treated in the hospital will become zero between mid-March and mid-April in mainland China beyond Hubei Province. The framework proposed in this paper can help people get a general understanding of the epidemic trends in counties where COVID-19 are raging as well as any other outbreaks of new and unknown infectious diseases in the future.","published":"10.12688\/f1000research.23107.1","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20034504","title":"High risk of infection caused posttraumatic stress symptoms in individuals with poor sleep quality: A study on influence of coronavirus disease (COVID-19) in China","authors":"Zhang, F.; Shang, Z.; Ma, H.; Jia, Y.; Sun, L.; Guo, X.; Wu, L.; Sun, Z.; Zhou, Y.; Wang, Y.; Liu, N.; Liu, W.","author_corresponding":"Weizhi Liu","author_corresponding_institution":"Naval Medical University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20034504.source.xml","abstract":"The influence of the outbreak of coronavirus disease (COVID-19) on mental health was poorly understood. The present study aimed to exam sleep problems and posttraumatic stress symptoms (PTSS) in Chinese immediately after the massive outbreak of COVID-19. A total of 2027 Chinese participated in the present study. Wuhan-expose history, sleep quality and PTSS were measured with self-rating scales. Results showed that there were significant differences of PCL-5 and of sleep quality scores in different data-collection dates (ps<0.05). There were significant differences of PCL-5 scores (t=-2.93, p<0.05) and latency onset of sleep ({chi}2=9.77, p<0.05) between participants with and without Wuhan-expose history. The interaction effect of Wuhan exposure historyx sleep quality significantly influenced PCL-5 (ps<0.05). These results indicate that keeping good sleep quality in individuals with high infectious risk is a way to prevent PTSS.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20040899","title":"Analysis of psychological state and clinical psychological intervention model of patients with COVID-19","authors":"Yang, L.; Wu, D.; Hou, Y.; Wang, X.; Dai, N.; Wang, G.; Yang, Q.; Zhao, W.; Lou, Z.; Ji, Y.; Ruan, L.","author_corresponding":"Zhongze Lou","author_corresponding_institution":"Department of Psychosomatic Medicine, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang 315211, P.R. China","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20040899.source.xml","abstract":"BackgroundPatients with the 2019 coronavirus disease (COVID-19) have different degrees of psychological pain, such as anxiety and depression, which may related to their prognosis. Psychological intervention can be conducted in different ways to improve psychological pain and improve the treatment effect.\n\nObjectiveThe present study aimed to investigate and analyze the psychological status of patients with COVID-19 during the course of illness, and to evaluate the effect and influencing factors of psychological crisis intervention, so as to explore the effective mode of clinical psychological intervention in acute patients under isolation environment.\n\nMethodsA total of 143 persons participated in the study, including 26 patients diagnosed with COVID-19 in the isolation ward (COVID-19 group), 87 patients with general pneumonia in the observation ward (General Pneumonia group) and 30 healthy volunteers (Normal group). All the patients in the ward received comprehensive psychological intervention, including telephone psychological counseling (active and passive), self-adjustment of written materials and one-to-one psychological crisis intervention. Hamilton depression scale (HAMD) and Hamilton anxiety scale (HAMA) were used to evaluate the mental health status of all patients on the day of admission and 1 week after treatment.\n\nResultsThe scores of HAMA and HAMD of all patients (including isolation ward and observation ward) were significantly higher than the healthy volunteers at the time of admission. The total score of HAMA and HAMD in CVOID-19 group were both higher than that General Pneumonia group. After 1 weeks hospitalization with comprehensive psychological intervention, the scores of HAMA and HAMD in CVOID-19 group were significantly decreased.\n\nConclusionPatients those who diagnosed with COVID-19 in the isolation ward and\/or general pneumonia in observation ward have different degrees of anxiety, depression and sleep problems. While receiving antiviral treatment, patients also need psychological intervention. Comprehensive psychological intervention model has been proved to be effective.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20040287","title":"Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults","authors":"Banerjee, A.; Pasea, L.; Harris, S.; Gonzalez-Izquierdo, A.; Torralbo, A.; Shallcross, L.; Noursadeghi, M.; Pillay, D.; Pagel, C.; Wong, W. K.; Langenberg, C.; Williams, B.; Denaxas, S.; Hemingway, H.","author_corresponding":"Amitava Banerjee","author_corresponding_institution":"University College London","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20040287.source.xml","abstract":"BackgroundThe medical, health service, societal and economic impact of the COVID-19 emergency has unknown effects on overall population mortality. Previous models of population mortality are based on death over days among infected people, nearly all of whom (to date at least) have underlying conditions. Models have not incorporated information on high risk conditions or their longer term background (pre-COVID-19) mortality. We estimated the excess number of deaths over 1 year under different COVID-19 incidence rates and differing mortality impacts.\n\nMethodsUsing population based linked primary and secondary care electronic health records in England (HDR UK - CALIBER), we report the prevalence of underlying conditions defined by UK Public Health England COVID-19 guidelines (16 March 2020) in 3,862,012 individuals aged [&ge;]30 years from 1997-2017. We used previously validated phenotypes, openly available (https:\/\/caliberresearch.org\/portal), for each condition using ICD-10 diagnosis, Read, procedure and medication codes. We estimated the 1-year mortality in each condition, and developed simple models of excess COVID-19-related deaths assuming relative risk (RR) of the impact of the emergency (compared to background mortality) of 1.2, 1.5 and 2.0.\n\nFindings20.0% of the population are at risk according to current PHE guidelines, of which; 13.7% were age>70 years and 6.3% aged [&le;]70 years with [&ge;]1 underlying condition (cardiovascular disease (2.3%), diabetes (2.2%), steroid therapy (1.9%), severe obesity (0.9%), chronic kidney disease (0.6%) and chronic obstructive pulmonary disease, COPD (0.5%). Multimorbidity (co-occurrence of [&ge;]2 conditions in an individual) was common (10.1%). The 1-year mortality in the at-risk population was 4.46%, and age and underlying conditions combine to influence background risk, varying markedly across conditions (5.9% in age>70 years, 8.6% for COPD and 13.1% in those with [&ge;]3 or more conditions). In a suppression scenario (at SARS CoV2 rates of 0.001% of the UK population), there would be minimal excess deaths (3 and 7 excess deaths at relative risk, RR, 1.5 and 2.0 respectively). At SARS CoV2 rates of 10% of the UK population (mitigation) the model estimates the numbers of excess deaths as: 13791, 34479 and 68957 (at RR 1.2, 1.5 and 2.0 respectively). At SARS CoV2 rates of 80% in the UK population (\"do-nothing\"), the model estimates the number of excess deaths as 110332, 275,830 and 551,659 (at RR 1.2, 1.5 and 2.0) respectively.\n\nInterpretationWe provide the public, researchers and policy makers a simple model to estimate the excess mortality over 1 year from COVID-19, based on underlying conditions at different ages. If the relative mortality impact of COVID-19 were to be about 20% (similar magnitude as the established winter vs summer mortality excess), then the excess deaths would be 0 when 1 in 100 000 (suppression), 13791 when 1 in 10 (mitigation) and 110332 when 8 in 10 are infected (\"do nothing\") scenario. However, the relative impact of COVID-19 is unknown. If the emergency were to double the mortality risk, then we estimate 7, 68957 and 551,659 excess deaths in the same scenarios. These results may inform the need for more stringent suppression measures as well as efforts to target those at highest risk for a range of preventive interventions.","published":"10.1016\/s0140-6736(20)30854-0","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038703","title":"Differential transcript usage unravels transcriptional alterations in Alzheimer's disease human brains","authors":"Coelho, D. M.; Carvalho, L. I. d. C.; Lambert, J.-C.; Costa, M. R.","author_corresponding":"Marcos Romualdo Costa","author_corresponding_institution":"Institut Pasteur de Lille","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.19.20038703.source.xml","abstract":"Alzheimers disease (AD) is the leading cause of dementia in aging individuals. However pathophysiological processes involved in the brain are still poorly understood. Among numerous strategies, a comprehensive overview of gene expression alterations in the diseased brain has been proposed to help for a better understanding of the disease processes. In this work, we probed the differential expression of genes in different brain regions of healthy and AD adult subjects using data from three large studies: MAYO Clinic; Mount Sinai Brain Bank (MSBB) and ROSMAP. Using a combination of differential expression of gene (DEG) and isoform switch analyses we provide a detailed landscape of gene expression alterations in the temporal and frontal lobes, harboring brain areas affected at early and late stages of the AD pathology, respectively. Next, we took advantage of an indirect approach to assign the complex gene expression changes revealed in bulk RNAseq to individual cell types of the adult brain. This strategy allowed us to identify cell type\/subtype specific isoform switches in AD brains previously overlooked. This was the case, for example, for the AD causal gene APP and the risk gene BIN1, which presented isoform switches with potential functional consequences in neuronal cells. Altogether, our work proposes a novel integrative strategy to analyze RNAseq data in AD based on both gene\/transcript expression and regional\/cell-type specificities.","published":"10.1038\/s41514-020-00052-5","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20031336","title":"Characterizing occupations that cannot work from home: a means to identify susceptible worker groups during the COVID-19 pandemic","authors":"Baker, M. G.","author_corresponding":"Marissa G. Baker","author_corresponding_institution":"University of Washington","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"occupational and environmental health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20031336.source.xml","abstract":"ObjectivesNot all workers are employed in occupations in which working from home is possible. These workers are at an increased risk for exposure to infectious disease during a pandemic event, and are more likely to experience events of job displacement and disruption during all types of public health emergencies. Here, I characterized which occupational sectors in the United States are most able to work from home during a public health emergency such as COVID-19.\n\nMethods2018 national employment and wage data maintained by the U.S. Bureau of Labor Statistics (BLS) was merged with measures from the BLS O*NET survey data. The measures utilized rank the importance of using a computer at work, and the importance of working with or performing for the public, which relate to the ability to complete work at home.\n\nResultsAbout 25% (35.6 M) of the U.S. workforce are employed in occupations which could be done from home, primarily in sectors such as technology, computer, management, administrative, financial, and engineering. The remaining 75% of U.S. workers (including healthcare, manufacturing, retail and food services, et al.) are employed in occupations where working from home would be difficult.\n\nConclusionsThe majority of U.S. workers are employed in occupations that cannot be done at home, putting 108.4 M U.S. workers at increased risk for adverse health outcomes related to working during a public health emergency. These workers tend to be lower paid than workers who can work from home. During COVID-19, this could result in a large increase in the burden of mental health disorders in the U.S., in addition to increased cases of COVID-19 due to workplace transmission. Public health guidance to \"work from home\" is not applicable to the majority of the U.S. workforce, emphasizing the need for additional guidance for workers during public health emergencies.","published":"10.2105\/AJPH.2020.305738","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20037051","title":"Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan","authors":"Xie, C.; Wang, X.; Liu, H.; Bao, Z.; Yu, J.; Zhong, Y.; Chua, M. L.","author_corresponding":"Conghua Xie","author_corresponding_institution":"Zhongnan Hospital of Wuhan University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20037051.source.xml","abstract":"BackgroundA pandemic of 2019 novel corona virus disease (COVID-19), which was first reported in Wuhan city, has affected more than 100,000 patients worldwide. Patients with cancer are at a higher risk of COVID-19, but currently, there is no guidance on the management of cancer patients during this outbreak. Here, we report the infection control measures and early outcomes of patients who received radiotherapy (RT) at a tertiary cancer centre in Wuhan.\n\nMethodsWe reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020. This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcare staff. Diagnosis of COVID-19 was based on the 5th edition criteria.\n\nFindings209 patients completed RT during the study period. Median age was 55 y (IQR = 48-64). Thoracic, head and neck, and lower gastrointestinal and gynaecological cancer patients consisted the majority of patients. Treatment sites included thoracic (38.3%), head and neck (25.4%), and abdomen and pelvis (25.8%); 47.4%, 27.3%, and 25.4% of treatments were for adjuvant, radical, and palliative indications, respectively. 188 treatments\/day were performed prior to the lock-down, in contrast to 12.4 treatments\/day post-lock-down. Only one (0.48%) patient was diagnosed with COVID-19 during the study period. No healthcare worker was infected.\n\nInterpretationHerein, we show that in a susceptible population to COVID-19, strict infection control measures can curb human-to-human transmission, and ensure timely delivery of RT to cancer patients.\n\nFundingThis study was funded by Health Commission of Hubei Province Scientific Research Project, WJ2019H002, Health Commission of Hubei Province Medical Leading Talent Project.\n\nResearch in contextO_ST_ABSEvidence before this studyC_ST_ABSThe 2019 novel coronavirus disease (COVID-19) is now a global pandemic. Cancer patients are at risk of COVID-19 pneumonia, and thus infection control measures are crucial to mitigate their risk of infection. We searched PubMed and Medline for articles published up to Mar 12, 2020, using the following keywords: \"COVID-19\", \"SARS\", \"SARS-CoV-2\", \"infection control\", and \"cancer\". No evidence exists that informs on the appropriate infection control measures for COVID-19.\n\nAdded value of this studyWe report our single centre experience on the detailed infection control measures that were undertaken to minimise cross transmission between cancer patients undergoing radiotherapy, and between patients and healthcare workers. Measures entailing screening of suspect cases, re-organisation of the treatment facility, and protection of healthcare workers were described. With our infection control protocol, we recorded only one COVID-19 case among the 209 patients (0.48%) who were treated at our centre during the period of Jan 20 to Mar 6, 2020. No healthcare worker was affected.\n\nImplications of all the available evidenceThe effective infection control measures outlined in this study will help institutions worldwide affected by COVID-19 to formulate guidelines to mitigate nosocomial human-to-human transmission, especially among susceptible patients.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.22.20034041","title":"First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients","authors":"Chen, H.; Zhang, Z.; Wang, L.; Huang, Z.; Gong, F.; Li, X.; Chen, Y.; WU, J. J.","author_corresponding":"Jinzi J. WU","author_corresponding_institution":"Ascletis Bioscience Co., Ltd., Hangzhou, Zhejiang province, China","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.22.20034041.source.xml","abstract":"As coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), started in China in January, 2020, repurposing approved drugs is emerging as important therapeutic options. We reported here the first clinical study using hepatitis C virus (HCV) protease inhibitor, danoprevir, to treat COVID-19 patients. Danoprevir (Ganovo(R)) is a potent HCV protease (NS3\/4A) inhibitor (IC50 = 0.29 nM), which was approved and marketed in China since 2018 to treat chronic hepatitis C patients. Ritonavir is a CYP3A4 inhibitor to enhance plasma concentration of danoprevir while it also acts as a human immunodeficiency virus (HIV) protease inhibitor at high doses. The chymotrypsin-like protease of SARS-CoV-2 shares structure similarity with HCV and HIV proteases. In the current clinical study (NCT04291729) conducted at the Nineth Hospital of Nanchang, we evaluated therapeutic effects of danoprevir, boosted by ritonavir, on treatment naive and experienced COVID-19 patients. The data from this small-sample clinical study showed that danoprevir boosted by ritonavir is safe and well tolerated in all patients. After 4 to 12-day treatment of danoprevir boosted by ritonavir, all eleven patients enrolled, two naive and nine experienced, were discharged from the hospital as they met all four conditions as follows: (1) normal body temperature for at least 3 days; (2) significantly improved respiratory symptoms; (3) lung imaging shows obvious absorption and recovery of acute exudative lesion; and (4) two consecutive RT-PCR negative tests of SARS-CoV-2 nucleotide acid (respiratory track sampling with interval at least one day). Our findings suggest that repurposing danoprevir for COVID-19 is a promising therapeutic option.","published":"10.1097\/md.0000000000023357","server":"medrxiv"},{"doi":"10.1101\/2020.03.19.20038794","title":"MATHEMATICAL PREDICTIONS FOR COVID-19 AS A GLOBAL PANDEMIC","authors":"Victor, A. O.","author_corresponding":"Alexander Okhuese Victor","author_corresponding_institution":"Nasarawa State University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.19.20038794.source.xml","abstract":"This study shows that the disease free equilibrium (E0) for COVID-19 coronavirus does not satisfy the criteria for a locally or globally asymptotic stability. This implies that as a pandemic as declared by WHO (2020) the COVID-19 coronavirus does not have a curative vaccine yet and precautionary measures are advised through quarantine and observatory procedures. Also, the Basic Reproductive number (R0 < 1) by Equation (33) shows that there is a chance of decline of secondary infections when the ratio between the incidence rate in the population and the total number of infected population quarantined with observatory procedure.\n\nThe effort to evaluate the disease equilibrium shows that unless there is a dedicated effort from government, decision makers and stakeholders, the world would hardly be reed of the COVID-19 coronavirus and further spread is eminent and the rate of infection will continue to increase despite the increased rate of recovery because of the absence of vaccine at the moment.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20040691","title":"Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial","authors":"Bian, H.; Zheng, Z.-H.; Wei, D.; Zhang, Z.; Kang, W.-Z.; Hao, C.-Q.; Dong, K.; Kang, W.; Xia, J.-L.; Miao, J.-L.; Xie, R.-H.; Wang, B.; Sun, X.-X.; Yang, X.-M.; Lin, P.; Geng, J.-J.; Wang, K.; Cui, H.-Y.; Zhang, K.; Chen, X.-C.; Tang, H.; Du, H.; Yao, N.; Liu, S.-S.; Liu, L.-N.; Zhang, Z.; Gao, Z.-W.; Nan, G.; Wang, Q.-Y.; Lian, J.-Q.; Chen, Z.-N.; Zhu, P.","author_corresponding":"Ping Zhu","author_corresponding_institution":"Xijing Hospital, Fourth Military Medical University","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20040691.source.xml","abstract":"BackgroundSARS-CoV-2 is a novel human coronavirus, there is no specific antiviral drugs. It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 and involve in host cell invasion. Antibody against CD147 could block the infection of SARS-CoV-2. We aimed to assess the efficacy and safety of meplazumab, a humanized anti-CD147 antibody, as add-on therapy in patients with COVID-19 pneumonia.\n\nMethodsAll patients received recommended strategy from Diagnosis and Treatment for 2019 Novel Coronavirus Diseases released by National Health Commission of China. Eligible patients were add-on administered 10 mg meplazumab intravenously at days 1, 2, and 5. Patients hospitalized in the same period were observed as concurrent control. The endpoints include virological clearance rate, case severity, chest radiographic, and laboratory test. This trial was approved by the Ethics Committee of Institution at the Tangdu hospital, and registered with ClinicalTrials.gov, NCT 04275245.\n\nFindings17 patients were enrolled and assigned to meplazumab group between Feb 3, 2020 and Feb 10, 2020. 11 hospitalized patients served as concurrent control. Baseline characteristics were generally balanced across two groups. Compared to control group, meplazumab treatment significantly improved the discharged (p=0.006) and case severity (p=0.021) in critical and severe patients. The time to virus negative in meplazumab group was reduced than that in control group (median 3, 95%CI[1.5-4.5] vs. 13, [6.5-19.5]; p=0.014, HR=0.37, 95%CI[0.155-0.833]). The percentages of patients recovered to the normal lymphocyte count and CRP concentration were also increased remarkably and rapidly in meplazumab group. No adverse effect was found in meplazumab-treated patients.\n\nInterpretationMeplazumab efficiently improved the recovery of patients with SARS-CoV-2 pneumonia with a favorable safety profile. Our results support to carry out a large-scale investigation of meplazumab as a treatment for COVID-19 pneumonia.\n\nFundingNational Science and Technology Major Project.","published":"NA","server":"medrxiv"},{"doi":"10.1101\/2020.03.21.20037267","title":"Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study","authors":"Ma, L.; Xie, W.; Li, D.; Shi, L.; Mao, Y.; Xiong, Y.; Zhang, Y.; Zhang, M.","author_corresponding":"Ming Zhang","author_corresponding_institution":"Reproductive Medicine Center, Zhongnan Hospital, Wuhan University; Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health,","date":"2020-03-24","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"sexual and reproductive health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/24\/2020.03.21.20037267.source.xml","abstract":"Since SARS-CoV-2 infection was first identified in December 2019, it spread rapidly and a global pandemic of COVID-19 has occurred. ACE2, the receptor for entry into the target cells by SARS-CoV-2, was found to abundantly express in testes, including spermatogonia, Leydig and Sertoli cells. However, there is no clinical evidence about whether SARS-CoV-2 infection can affect male gonadal function so far. In this study, we compared the sex-related hormones between 81 reproductive-aged men with SARS-CoV-2 infection and 100 age-matched healthy men, and found that serum luteinizing hormone (LH) was significantly increased, but the ratio of testosterone (T) to LH and the ratio of follicle stimulating hormone (FSH) to LH were dramatically decreased in males with COVID-19. Besides, multivariable regression analysis indicated that c-reactive protein (CRP) level was significantly associated with serum T:LH ratio in COVID-19 patients. This study provides the first direct evidence about the influence of medical condition of COVID-19 on male sex hormones, alerting more attention to gonadal function evaluation among patients recovered from SARS-CoV-2 infection, especially the reproductive-aged men.","published":"NA","server":"medrxiv"}]}